{"text_format":"1","workbook":"xlsx","n_sheets":78,"sheets":["Zoznam","tabuľka_1","tabuľka_2","tabuľka_3","tabuľka_4","tabuľka_5","tabuľka_6","tabuľka_7","tabuľka_8","tabuľka_9","tabuľka_10","tabuľka_11","tabuľka_12","tabuľka_13","tabuľka_14","tabuľka_15","tabuľka_16","tabuľka_17","tabuľka_18","tabuľka_19","tabuľka_20","tabuľka_21","tabuľka_22","tabuľka_23","tabuľka_24","tabuľka_25","tabuľka_26","tabuľka_27","tabuľka_28","graf_1","graf_2","graf_3","graf_4","graf_5","graf_6","graf_7","graf_8","graf_9","graf_10","graf_11","graf_12","graf_13","graf_14","graf_15","graf_16","graf_17","graf_18","graf_19","graf_20","graf_21","graf_22","graf_23","graf_24","graf_25","graf_26","graf_27","graf_28","graf_29","graf_30","graf_31","graf_32","graf_33","graf_34","graf_35","graf_36","graf_37","graf_38","graf_39","graf_40","graf_41","graf_42","graf_43","graf_44","graf_45","graf_46","graf_47","graf_48","graf_49"],"not_rendered":{"charts":0,"images":4,"macros":1,"external_links":2,"defined_names":67,"comments":1,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900"}

{"sheet":"Zoznam","index":0,"n_rows":54,"n_cols":5,"rows_kept":54,"cut":false,"hidden":false,"merged":[[3,3,3,4],[3,0,3,1]]}
["Revízia výdavkov na zdravotníctvo II."]
["Zdrojové dáta pre grafy a tabuľky v priebežnej správe"]
[]
["Tabuľky",null,null,"Grafy"]
["Názov:","Odkaz",null,"Názov:","Odkaz"]
["Tabuľka 1: Prehľad najpredávanejších biologických liekov",{"$f":"HYPERLINK(\"#tabuľka_1!A1\", \"tabuľka_1\")","v":"tabuľka_1"},null,"Graf 1: Odvrátiteľná úmrtnosť (na 100 000 obyvateľov)",{"$f":"HYPERLINK(\"#graf_1!A1\", \"graf_1\")","v":"graf_1"}]
["Tabuľka 2: Prehľad kategorizovaných biosimilárnych liekov v krajinách V4, august 2018",{"$f":"HYPERLINK(\"#tabuľka_2!A1\", \"tabuľka_2\")","v":"tabuľka_2"},null,"Graf 2: Očakávaná dĺžka života žien pri narodení",{"$f":"HYPERLINK(\"#graf_2!A1\", \"graf_2\")","v":"graf_2"}]
["Tabuľka 3: Povinné zníženie ceny pri vstupe nového lieku do kategorizácie, platné od januára 2018",{"$f":"HYPERLINK(\"#tabuľka_3!A1\", \"tabuľka_3\")","v":"tabuľka_3"},null,"Graf 3: Počet lekárov (na 1 000 obyv.), 2017",{"$f":"HYPERLINK(\"#graf_3!A1\", \"graf_3\")","v":"graf_3"}]
["Tabuľka 4: Charakteristiky nemocničnej zdravotnej starostlivosti v rokoch 2017 a 2030",{"$f":"HYPERLINK(\"#tabuľka_4!A1\", \"tabuľka_4\")","v":"tabuľka_4"},null,"Graf 4: Počet lekárov podľa špecializácií",{"$f":"HYPERLINK(\"#graf_4!A1\", \"graf_4\")","v":"graf_4"}]
["Tabuľka 5: Záväzky po lehote splatnosti podľa zriaďovateľa nemocnice",{"$f":"HYPERLINK(\"#tabuľka_5!A1\", \"tabuľka_5\")","v":"tabuľka_5"},null,"Graf 5: Počet zdravotných sestier (na 1 000 obyv.), 2000 a 2015",{"$f":"HYPERLINK(\"#graf_5!A1\", \"graf_5\")","v":"graf_5"}]
["Tabuľka 6: Výnosy a náklady 13 najväčších univerzitných a fakultných nemocníc MZ",{"$f":"HYPERLINK(\"#tabuľka_6!A1\", \"tabuľka_6\")","v":"tabuľka_6"},null,"Graf 6: Počet zdravotných sestier (Practising nurses, na 1 000 obyv.), 2016 ",{"$f":"HYPERLINK(\"#graf_6!A1\", \"graf_6\")","v":"graf_6"}]
["Tabuľka 7: Dojčenská úmrtnosť (na 1 000 živonarodených)",{"$f":"HYPERLINK(\"#tabuľka_7!A1\", \"tabuľka_7\")","v":"tabuľka_7"},null,"Graf 7: Veková štruktúra, lekári a sestry, 2016",{"$f":"HYPERLINK(\"#graf_7!A1\", \"graf_7\")","v":"graf_7"}]
["Tabuľka 8: Výdavky verejného zdravotného poistenia (VZP), 2017",{"$f":"HYPERLINK(\"#tabuľka_8!A1\", \"tabuľka_8\")","v":"tabuľka_8"},null,"Graf 8: Veková štruktúra, lekári podľa špecializácií (%), 2016",{"$f":"HYPERLINK(\"#graf_8!A1\", \"graf_8\")","v":"graf_8"}]
["Tabuľka 9: Rozpočet Ministerstva zdravotníctva podľa programov",{"$f":"HYPERLINK(\"#tabuľka_9!A1\", \"tabuľka_9\")","v":"tabuľka_9"},null,"Graf 9: Verejné výdavky na lieky* na osobu, bežné ceny, EUR,2016",{"$f":"HYPERLINK(\"#graf_9!A1\", \"graf_9\")","v":"graf_9"}]
["Tabuľka 10. Rozpočet v zdravotníctve (mil. eur)",{"$f":"HYPERLINK(\"#tabuľka_10!A1\", \"tabuľka_10\")","v":"tabuľka_10"},null,"Graf 10: Celková spotreba liekov (v denných dávkach, na 1 000 obyv.)",{"$f":"HYPERLINK(\"#graf_10!A1\", \"graf_10\")","v":"graf_10"}]
["Tabuľka 11: Príklad programovej štruktúry – program Ústavná zdravotná starostlivosť",{"$f":"HYPERLINK(\"#tabuľka_11!A1\", \"tabuľka_11\")","v":"tabuľka_11"},null,"Graf 11: Porovnanie zahraničnej a slovenskej spotreby liekov v jednotlivých ATC skupinách, 2016",{"$f":"HYPERLINK(\"#graf_11!A1\", \"graf_11\")","v":"graf_11"}]
["Tabuľka 12: Skutočne vybrané zdroje v zdravotníctve (mil. eur)",{"$f":"HYPERLINK(\"#tabuľka_12!A1\", \"tabuľka_12\")","v":"tabuľka_12"},null,"Graf 12: Spotreba antibiotík (definované denné dávky na 1 000 obyv./deň)",{"$f":"HYPERLINK(\"#graf_12!A1\", \"graf_12\")","v":"graf_12"}]
["Tabuľka 13: Zmeny výdavkov - VZP - súhrn",{"$f":"HYPERLINK(\"#tabuľka_13!A1\", \"tabuľka_13\")","v":"tabuľka_13"},null,"Graf 13: Spotreba generík (podiel generík na celkovej spotrebe liekov uhrádzaných z VZP, %)",{"$f":"HYPERLINK(\"#graf_13!A1\", \"graf_13\")","v":"graf_13"}]
["Tabuľka 14: Zmeny výdavkov - VZP - bez zmien politík",{"$f":"HYPERLINK(\"#tabuľka_14!A1\", \"tabuľka_14\")","v":"tabuľka_14"},null,"Graf 14: Výdavky na generiká (podiel generík na celkových výdavkoch na lieky uhrádzaných z VZP, %)",{"$f":"HYPERLINK(\"#graf_14!A1\", \"graf_14\")","v":"graf_14"}]
["Tabuľka 15: Zmeny výdavkov - VZP - zmeny politík",{"$f":"HYPERLINK(\"#tabuľka_15!A1\", \"tabuľka_15\")","v":"tabuľka_15"},null,"Graf 15: Rozptyl medzi 65 nemocnicami v kvalite zdravotnej starostlivosti",{"$f":"HYPERLINK(\"#graf_15!A1\", \"graf_15\")","v":"graf_15"}]
["Tabuľka 16: Zmeny výdavkov - VZP - úsporné opatrenia - Hodnota za peniaze (mil. eur)",{"$f":"HYPERLINK(\"#tabuľka_16!A1\", \"tabuľka_16\")","v":"tabuľka_16"},null,"Graf 16: Počet čakajúcich na plánované výkony k 31.12.",{"$f":"HYPERLINK(\"#graf_16!A1\", \"graf_16\")","v":"graf_16"}]
["Tabuľka 17: Zmeny výdavkov – nemocnice (mil. eur)",{"$f":"HYPERLINK(\"#tabuľka_17!A1\", \"tabuľka_17\")","v":"tabuľka_17"},null,"Graf 17: Podiel populácie s časom dojazdu do 30 minút do najbližšej nemocnice",{"$f":"HYPERLINK(\"#graf_17!A1\", \"graf_17\")","v":"graf_17"}]
["Tabuľka 18: Opatrenia s ďalším potenciálom pre zefektívnenie",{"$f":"HYPERLINK(\"#tabuľka_18!A1\", \"tabuľka_18\")","v":"tabuľka_18"},null,"Graf 18: Faktory ovplyvňujúce nárast záväzkov podľa účtovných závierok 13 univerzitných a fakultných nemocníc, 2017",{"$f":"HYPERLINK(\"#graf_18!A1\", \"graf_18\")","v":"graf_18"}]
["Tabuľka 19: Výdavky VZP v štruktúre navrhovaných programov, mil. eur",{"$f":"HYPERLINK(\"#tabuľka_19!A1\", \"tabuľka_19\")","v":"tabuľka_19"},null,"Graf 19: Vývoj straty a nárastu záväzkov 13 univerzitných a fakultných nemocníc MZ",{"$f":"HYPERLINK(\"#graf_19!A1\", \"graf_19\")","v":"graf_19"}]
["Tabuľka 20: Prehľad minimálnych objemov vybraných výkonov podľa Leapfrog group",{"$f":"HYPERLINK(\"#tabuľka_20!A1\", \"tabuľka_20\")","v":"tabuľka_20"},null,"Graf 20: Percento zaočkovaných proti chrípke, populácia 65+",{"$f":"HYPERLINK(\"#graf_20!A1\", \"graf_20\")","v":"graf_20"}]
["Tabuľka 21: Rozdelenie nemocníc podľa ZS – prvý návrh zo štúdie",{"$f":"HYPERLINK(\"#tabuľka_21!A1\", \"tabuľka_21\")","v":"tabuľka_21"},null,"Graf 21: Percento žien (50-79), ktoré absolvovali skríning na rakovinu prsníka",{"$f":"HYPERLINK(\"#graf_21!A1\", \"graf_21\")","v":"graf_21"}]
["Tabuľka 22: Údaje o skríningu karcinómu kolorekta, 2017",{"$f":"HYPERLINK(\"#tabuľka_22!A1\", \"tabuľka_22\")","v":"tabuľka_22"},null,"Graf 22: Percento žien, ktoré absolvovali preventívnu prehliadku  u gynekológa (kŕčok maternice)",{"$f":"HYPERLINK(\"#graf_22!A1\", \"graf_22\")","v":"graf_22"}]
["Tabuľka 23: Výpočet dopadu rozšírenia skríningu rakoviny kolorekta",{"$f":"HYPERLINK(\"#tabuľka_23!A1\", \"tabuľka_23\")","v":"tabuľka_23"},null,"Graf 23: Podiel jednodňovej chirurgie na celkovom počte operácií",{"$f":"HYPERLINK(\"#graf_23!A1\", \"graf_23\")","v":"graf_23"}]
["Tabuľka 24: Vývoj úhrad zdravotných poisťovní za lieky na výnimky",{"$f":"HYPERLINK(\"#tabuľka_24!A1\", \"tabuľka_24\")","v":"tabuľka_24"},null,"Graf 24: Podiel návštev v ambulanciách špecializovanej starostlivosti zo všetkých (%)",{"$f":"HYPERLINK(\"#graf_24!A1\", \"graf_24\")","v":"graf_24"}]
["Tabuľka 25: Prehľad HTA* limitov k 1.1.2018",{"$f":"HYPERLINK(\"#tabuľka_25!A1\", \"tabuľka_25\")","v":"tabuľka_25"},null,"Graf 25: Počet CT strojov (na 1 mil. obyv.)",{"$f":"HYPERLINK(\"#graf_25!A1\", \"graf_25\")","v":"graf_25"}]
["Tabuľka 26: Výsledky v zdravotníctve - úroveň hodnotenia 1: zdravotný stav obyvateľstva",{"$f":"HYPERLINK(\"#tabuľka_26!A1\", \"tabuľka_26\")","v":"tabuľka_26"},null,"Graf 26: Počet CT vyšetrení (na 1 000 obyv.)",{"$f":"HYPERLINK(\"#graf_26!A1\", \"graf_26\")","v":"graf_26"}]
["Tabuľka 27: Lieky a zdravotnícke pomôcky",{"$f":"HYPERLINK(\"#tabuľka_27!A1\", \"tabuľka_27\")","v":"tabuľka_27"},null,"Graf 27: Počet MR strojov (na 1 mil. obyv.)",{"$f":"HYPERLINK(\"#graf_27!A1\", \"graf_27\")","v":"graf_27"}]
["Tabuľka 28: Prehľad odhadovaných úspor VZP podľa spôsobu stanovenia úhrad liekov",{"$f":"HYPERLINK(\"#tabuľka_28!A1\", \"tabuľka_28\")","v":"tabuľka_28"},null,"Graf 28: Počet MR vyšetrení (na 1 000 obyv.)",{"$f":"HYPERLINK(\"#graf_28!A1\", \"graf_28\")","v":"graf_28"}]
[null,null,null,"Graf 29: Nárasty počtu vyšetrení na CT a MR v rokoch 2016 – 2018",{"$f":"HYPERLINK(\"#graf_29!A1\", \"graf_29\")","v":"graf_29"}]
[null,null,null,"Graf 30: Počet PET strojov (na 1 mil. obyv.)",{"$f":"HYPERLINK(\"#graf_30!A1\", \"graf_30\")","v":"graf_30"}]
[null,null,null,"Graf 31:  Počet PET vyšetrení (na 1 000 obyv.)",{"$f":"HYPERLINK(\"#graf_31!A1\", \"graf_31\")","v":"graf_31"}]
[null,null,null,"Graf 32: Úmrtnosť na infarkt myokardu do 30 dní od hospitalizácie (na 100 000 obyv., vo veku 45+)",{"$f":"HYPERLINK(\"#graf_32!A1\", \"graf_32\")","v":"graf_32"}]
[null,null,null,"Graf 33: Počet čakateľov na poskytovanie starostlivosti v zariadeniach sociálnych služieb",{"$f":"HYPERLINK(\"#graf_33!A1\", \"graf_33\")","v":"graf_33"}]
[null,null,null,"Graf 34: Počet hospitalizácií, resp. pacientov podľa typu dlhodobej starostlivosti, 2017",{"$f":"HYPERLINK(\"#graf_34!A1\", \"graf_34\")","v":"graf_34"}]
[null,null,null,"Graf 35: Dĺžka pobytu a náklady na dlhodobú starostlivosť podľa typu služby, 2017",{"$f":"HYPERLINK(\"#graf_35!A1\", \"graf_35\")","v":"graf_35"}]
[null,null,null,"Graf 36: Počet hospitalizácií s diagnózou, ktorá má byť manažovaná domácou starostlivosťou, populácia 65+",{"$f":"HYPERLINK(\"#graf_36!A1\", \"graf_36\")","v":"graf_36"}]
[null,null,null,"Graf 37: Dojčenská úmrtnosť (počet smrtí v prvom roku života na 1 000 živonarodených)",{"$f":"HYPERLINK(\"#graf_37!A1\", \"graf_37\")","v":"graf_37"}]
[null,null,null,"Graf 38: Očakávaná dĺžka života pri narodení (v rokoch)",{"$f":"HYPERLINK(\"#graf_38!A1\", \"graf_38\")","v":"graf_38"}]
[null,null,null,"Graf 39: Vzťah bohatstva krajiny a výdavkov na zdravotníctvo, 2017",{"$f":"HYPERLINK(\"#graf_39!A1\", \"graf_39\")","v":"graf_39"}]
[null,null,null,"Graf 40: Výdavky na zdravotníctvo ako % verejných výdavkov",{"$f":"HYPERLINK(\"#graf_40!A1\", \"graf_40\")","v":"graf_40"}]
[null,null,null,"Graf 41: Vzťah medzi zdravotným stavom obyvateľstva a výdavkami na zdravotníctvo, 2017",{"$f":"HYPERLINK(\"#graf_41!A1\", \"graf_41\")","v":"graf_41"}]
[null,null,null,"Graf 42: Výdavky na zdravotníctvo (% HDP)",{"$f":"HYPERLINK(\"#graf_42!A1\", \"graf_42\")","v":"graf_42"}]
[null,null,null,"Graf 43: Prognóza vývoja vekovej štruktúry obyvateľstva",{"$f":"HYPERLINK(\"#graf_43!A1\", \"graf_43\")","v":"graf_43"}]
[null,null,null,"Graf 44: Plat lekára ako násobok priemernej mzdy, 2015",{"$f":"HYPERLINK(\"#graf_44!A1\", \"graf_44\")","v":"graf_44"}]
[null,null,null,"Graf 45: Plat sestry ako násobok priemernej mzdy, 2015",{"$f":"HYPERLINK(\"#graf_45!A1\", \"graf_45\")","v":"graf_45"}]
[null,null,null,"Graf 46: Vzťah kvality a objemu zdravotnej starostlivosti",{"$f":"HYPERLINK(\"#graf_46!A1\", \"graf_46\")","v":"graf_46"}]
[null,null,null,"Graf 47:  Rozsah a medián objemu resekcie rakoviny pažeráka podľa poskytovateľa, 2014-2016",{"$f":"HYPERLINK(\"#graf_47!A1\", \"graf_47\")","v":"graf_47"}]
[null,null,null,"Graf 48: Výdavky poisťovní na lieky na výnimky v 1. polroku 2016, 2017 a 2018",{"$f":"HYPERLINK(\"#graf_48!A1\", \"graf_48\")","v":"graf_48"}]
[null,null,null,"Graf 49: Výdavky poisťovní na lieky na výnimky v prepočte na 1 000 poistencov v 1. polroku",{"$f":"HYPERLINK(\"#graf_49!A1\", \"graf_49\")","v":"graf_49"}]

{"sheet":"tabuľka_1","index":1,"n_rows":21,"n_cols":7,"rows_kept":21,"cut":false,"hidden":false,"merged":[[18,1,18,6],[19,1,19,6],[20,1,20,6],[0,1,0,6]]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Tabuľka 1: Prehľad najpredávanejších biologických liekov "]
[null,"Názov lieku","Účinná látka","Termín vypršania\npatentovej ochrany","Objem predaja v SR \nv mil. eur, 2017","Prvý registrovaný\nbiosimilárnyliek v EMA","Prvý kategorizovaný\nbiosimilárny liek v SR"]
[null,"Humira","adalimumab ",2018,45.5,"Áno (2017)","Nie"]
[null,"Avastin","bevacizumab ",2022,19.2,"Áno (2018)","Nie"]
[null,"Remicade","infliximab ",2015,14.5,"Áno (2013)","Áno (2014)"]
[null,"Lucentis","ranibizumab ",2022,12.3,"Nie","Nie"]
[null,"Herceptin","trastuzumab ",2014,11.2,"Áno (2017)","Nie*"]
[null,"Enbrel","etanercept ",2015,10.5,"Áno (2016)","Nie"]
[null,"MabThera","rituximab ",2013,10.5,"Áno (2017)","Nie*"]
[null,"Xolair","omalizumab ",2017,7.9,"Nie","Nie"]
[null,"Simponi","golimumab",2024,7.7,"Nie","Nie"]
[null,"Tysabri","natalizumab ",2015,6.1,"Nie","Nie"]
[null,"Neulasta","pegfilgrastim ",2017,4.2,"Nie","Nie"]
[null,"Erbitux","cetuximab",2014,4,"Nie","Nie"]
[null,"Lantus","insulin glargine ",2014,3.3,"Áno (2013)","Áno (2015)"]
[null,"Avonex","interferon beta-1a ",2015,2.9,"Nie","Nie"]
[null,"NovoLog/ Novorapid","insulin aspart ",2011,2.2999999999999998,"Nie","Nie"]
[null,"Spolu",null,null,162.1]
[null,"Pozn.: INEKO použil zdroje: Kawalec a kol. (2017) - termín vypršania patentovanej ochrany (s výnimkou Simponi a Erbitux, kde termíny dohľadal autor); IMS - objem predaja v SR za rok 2017; Farmaceutická fakulta UK - informácia o dostupnosti biosimilárnych liekov v EÚ a SR."]
[null,"* V júli a auguste 2018 MZ SR schválilo žiadosti o kategorizáciu troch biosimilárnych liekov s účinnými látkami rituximab a trastuzumab. Vstup liekov na trh sa očakáva najskôr v jeseni 2018."]
[null,"Zdroj: INEKO"]

{"sheet":"tabuľka_2","index":2,"n_rows":24,"n_cols":9,"rows_kept":24,"cut":false,"hidden":false,"merged":[[23,1,23,8],[0,1,0,8]]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Tabuľka 2: Prehľad kategorizovaných biosimilárnych liekov v krajinách V4, august 2018"]
[null,"Rok registrácie v EMA","Molekula","Názov lieku","Firma","SK","CZK","PL","HUN"]
[null,2006,"Somatropin","Omnitrope","Sandoz","-","áno","-"," áno"]
[null,2007,"Epoetin alfa","Binocrit","Sandoz","áno","áno","áno"," áno"]
[null,2007,"Epoetin zeta","Retacrit","Hospira","-","áno","-","áno"]
[null,2008,"Filgrastim","Ratiograstim","Ratiopharm","áno","-","-","áno"]
[null,2008,"Filgrastim","Tevagrastim","Teva Generics","-","áno","áno","-"]
[null,2009,"Filgrastim","Zarzio","Sandoz","áno","áno","áno","áno"]
[null,2010,"Filgrastim","Nivestim","Hospira","-","áno","áno","áno"]
[null,2013,"Filgrastim","Grastofil","Apotex","áno","-","áno","-"]
[null,2013,"Infliximab","Inflectra","Hospira","áno","áno","áno","áno"]
[null,2013,"Follitropin alfa","Ovaleap","Teva Pharma","-","áno","áno","áno"]
[null,2013,"Infliximab","Remsima","Celltrion","áno","áno","áno","áno"]
[null,2014,"Insulin glargine","Abasaglar","Eli Lilly/Boehringer Ingelheim","áno","áno","áno","áno"]
[null,2014,"Filgrastim","Accofil","Accord Healthcare","áno","áno","áno","áno"]
[null,2014,"Follitropin alfa","Bemfola","Finox Biotech","áno","áno","áno","áno"]
[null,2016,"Etanercept","Benepali","Samsung Bioepis","-","áno","áno","-"]
[null,2016,"Infliximab","Flixabi","Samsung Bioepis","-","áno","áno","-"]
[null,2017,"Etanercept","Erelzi","Sandoz","-","-","áno","-"]
[null,2017,"Rituximab","Truxima","Celltrion","-","áno","-","áno"]
[null,2017,"Trastuzumab","Herzuma","Celltrion","-","áno","-","áno"]
[null,2017,"Adalimumab","Imraldi","Samsung Bioepis",null,"áno","-","-"]
[null,"Spolu",null,null,null,9,17,14,14]
[null,"Zdroj: INEKO, dáta Farmaceutická fakulta UK"]

{"sheet":"tabuľka_3","index":3,"n_rows":5,"n_cols":5,"rows_kept":5,"cut":false,"hidden":false,"merged":[[4,1,4,4]]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Tabuľka 3: Povinné zníženie ceny pri vstupe nového lieku do kategorizácie, platné od januára 2018"]
[null,null,"1. liek v ref. skupine","2. liek v ref. skupine","3. a ďalší liek ref. skupine"]
[null,"Generický liek",-0.45,-0.1,-0.05]
[null,"Biosimilárny liek",-0.3,-0.05,-0.05]
[null,"Zdroj: aktuálne znenie zákona 363/2011 Z.z."]

{"sheet":"tabuľka_4","index":4,"n_rows":13,"n_cols":5,"rows_kept":13,"cut":false,"hidden":false,"merged":[[12,1,12,4],[11,1,11,4]]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Tabuľka 4: Charakteristiky nemocničnej zdravotnej starostlivosti v rokoch 2017 a 2030"]
[null,null,2017,2017,2030]
[null,null,"Krajiny záp. Európy","Slovensko súčasný systém","Slovensko súčasný systém"]
[null,"Počet pacientov, v mil.","-",1,1.2]
[null,"Počet lôžok","-",32300,37400]
[null,"Priemerná dĺžka hospitalizácie, v dňoch",6.5,8.3000000000000007,8.3000000000000007]
[null,"Obsadenosť lôžok",0.8,0.72,0.72]
[null,"Podiel obyvateľstva s dostupnosťou do 30 minút","86 %*",0.91,0.91]
[null,"Počet lekárov na lôžko",0.31,0.2,0.18]
[null,"Počet sestier na lôžko",0.69,0.52,0.45]
[null,"Prostriedky k dispozícii na lôžko pri fixnom rozpočte","-",29200,25200]
[null,"*Výpočet ÚHP s použitím dát v štúdii BCG"]
[null,"Zdroj: OECD, EUROSTAT,NCZI, MZ SR, BCG"]

{"sheet":"tabuľka_5","index":5,"n_rows":9,"n_cols":12,"rows_kept":9,"cut":false,"hidden":false,"merged":[[8,1,8,11],[0,1,0,11]]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Tabuľka 5: Záväzky po lehote splatnosti podľa zriaďovateľa nemocnice"]
[null,null,null,"Objem v mil. eur",null,null,null,null,"Rast v mil. eur"]
[null,null,null,2013,2014,2015,2016,2017,2014,2015,2016,2017]
[null,"V pôsobnosti MZ SR ",null,247,334,442,547,679,87,108,105,132]
[null,"V pôsobnosti MV SR, MO SR a MS SR",null,18,20,24,25,26,2,4,1,1]
[null,"Delimitované na obce a VÚC a transformované na n.o.",null,72,77,84,75,85,5,7,-9,10]
[null,"Transformované na akciové spoločnosti",null,0,0,0,0,1,0,0,0,1]
[null,"Záväzky po lehote splatnosti spolu",null,337,431,550,647,791,94,119,97,144]
[null,"Zdroj: MZ, ÚHP"]

{"sheet":"tabuľka_6","index":6,"n_rows":17,"n_cols":18,"rows_kept":17,"cut":false,"hidden":false,"merged":[[15,1,15,18],[16,1,16,18],[0,1,0,17],[1,4,1,9],[1,10,1,16],[2,12,2,13],[2,14,2,15],[3,1,3,3],[13,1,13,18],[14,1,14,18],[12,11,12,12],[12,13,12,14],[12,17,12,18],[8,1,8,3],[11,2,11,3],[12,1,12,3],[11,11,11,12],[11,13,11,14],[11,17,11,18],[9,2,9,3],[9,11,9,12],[9,13,9,14],[9,17,9,18],[10,2,10,3],[10,11,10,12],[10,13,10,14],[10,17,10,18],[7,11,7,12],[7,13,7,14],[7,17,7,18],[8,11,8,12],[8,13,8,14],[8,17,8,18],[5,11,5,12],[5,13,5,14],[5,17,5,18],[6,11,6,12],[6,13,6,14],[6,17,6,18],[4,2,4,3],[1,1,1,3],[2,1,2,3],[2,17,2,18],[3,11,3,12],[3,13,3,14],[3,17,3,18],[4,11,4,12],[4,13,4,14],[4,17,4,18]]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Tabuľka 6: Výnosy a náklady 13 najväčších univerzitných a fakultných nemocníc MZ"]
[null,null,null,null,"Objem  v mil. eur",null,null,null,null,null,"Rast",null,null,null,null,null,null,"Rozdiel oproti plánu v mil. eur"]
[null,null,null,null,2013,2014,2015,2016,2017,"2017 P*",2014,2015,2016,null,2017,null,"2017 P*",2017]
[null,"Výnosy celkom",null,null,682,685,719,762,784,785,4.0000000000000001E-3,0.05,null,0.06,null,2.9000000000000001E-2,1E-3,-1]
[null,null,"Výnosy zo ZP",null,606,637,663,707,721,718,5.0999999999999997E-2,4.1000000000000002E-2,null,6.6000000000000003E-2,null,0.02,-4.0000000000000001E-3,3]
[null,null,null,"VšZP",436,458,478,513,520,525,0.05,4.3999999999999997E-2,null,7.2999999999999995E-2,null,1.4E-2,0.01,-5]
[null,null,null,"Dôvera",132,137,142,148,156,148,3.7999999999999999E-2,3.7999999999999999E-2,null,4.2999999999999997E-2,null,4.9000000000000002E-2,-5.0999999999999997E-2,8]
[null,null,null,"Union",38,42,43,45,45,46,0.105,1.4E-2,null,6.3E-2,null,-1E-3,2.1999999999999999E-2,-1]
[null,"Náklady celkom",null,null,702,736,783,843,861,836,4.8000000000000001E-2,6.4000000000000001E-2,null,7.6999999999999999E-2,null,2.1000000000000001E-2,-2.9000000000000001E-2,25]
[null,null,"Osobné náklady",null,418,434,460,490,513,486,3.7999999999999999E-2,5.8999999999999997E-2,null,6.6000000000000003E-2,null,4.8000000000000001E-2,-5.2999999999999999E-2,27]
[null,null,"Lieky a ŠZM**",null,178,190,210,238,229,188,6.7000000000000004E-2,0.109,null,0.13100000000000001,null,-3.7999999999999999E-2,-0.17899999999999999,41]
[null,null,"Ostatné náklady",null,106,112,113,115,119,60,5.8000000000000003E-2,4.0000000000000001E-3,null,0.02,null,0.03,-0.496,59]
[null,"EBITDA***",null,null,-20,-51,-64,-81,-77,-52,1.55,0.255,null,0.26600000000000001,null,-4.9000000000000002E-2,-0.32500000000000001,-25]
[null,"*P – plán vo výkaze o hospodárení nemocníc MZ"]
[null,"**  Špeciálny zdravotnícky materiál, predstavuje invazívne zdravotnícke pomôcky, ktoré sa používajú takmer výlučne v ústavnej zdravotnej starostlivosti"]
[null,"***Prevádzkový hospodársky výsledok pred úrokmi, daňami, odpismi a amortizáciou "]
[null,"Zdroj: MZ"]

{"sheet":"tabuľka_7","index":7,"n_rows":8,"n_cols":9,"rows_kept":8,"cut":false,"hidden":false,"merged":[[7,1,7,8],[4,1,6,1],[1,2,3,2],[1,8,3,8],[0,1,0,8],[1,1,3,1],[1,3,3,3],[1,4,3,4],[1,5,3,5],[1,6,3,6],[1,7,3,7]]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Tabuľka 7: Výsledkové ukazovatele zdravotníctva"]
[null,"Ukazovateľ","SK/ Benchmark",2011,2012,2013,2014,2015,2016]
[]
[]
[null,"Dojčenská úmrtnosť na 1 000 živonarodených","SK",4.9000000000000004,5.8,5.5,5.8,5.0999999999999996,5.4]
[null,null,"V3",4.0999999999999996,4,4,3.7,3.6,3.6]
[null,null,"EU28",3.9,3.8,3.7,3.7,3.6,3.6]
[null,"Zdroj: OECD"]

{"sheet":"tabuľka_8","index":8,"n_rows":22,"n_cols":4,"rows_kept":22,"cut":false,"hidden":false,"merged":[[21,1,21,3],[20,1,20,3]]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Tabuľka 8: Výdavky verejného zdravotného poistenia (VZP), 2017"]
[null,null,"mil. eur","podiel z VZP"]
[null,"Zdravotná starostlivosť ",4341,0.94899999999999995]
[null,"Lieky, pomôcky",1258,0.27500000000000002]
[null,"Lieky a pomôcky",1070,0.23400000000000001]
[null,"Zdravotnícke pomôcky",188,4.1000000000000002E-2]
[null,"Ústavná zdravotná starostlivosť ",1276,0.27900000000000003]
[null,"Ambulantná zdravotná starostlivosť ",1044,0.22800000000000001]
[null,"Všeobecná zdravotná starostlivosť ",235,5.0999999999999997E-2]
[null,"Špecializovaná zdravotná starostlivosť ",809,0.17699999999999999]
[null,"SVLZ*",495,0.108]
[null,"Pohotovosť, záchranná služba, doprava",192,4.2000000000000003E-2]
[null,"Pohotovostná služba PP",16,3.0000000000000001E-3]
[null,"Záchranná zdravotná služba",87,1.9E-2]
[null,"Kúpeľná starostlivosť",52,1.0999999999999999E-2]
[null,"Doprava",26,6.0000000000000001E-3]
[null,"Vrtuľníková záchranná služba",11,2E-3]
[null,"Ostatné subjekty a iná ZS",76,1.7000000000000001E-2]
[null,"Iné výdavky zdravotných poisťovní**",235,5.0999999999999997E-2]
[null,"VZP spolu",4576]
[null,"*spoločné vyšetrovacie a liečebné zložky (napr. CT a MR) **napríklad výdavky na správu"]
[null,"Zdroj: MZ SR"]

{"sheet":"tabuľka_9","index":9,"n_rows":9,"n_cols":3,"rows_kept":9,"cut":false,"hidden":false,"merged":[[7,1,7,2]]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Tabuľka 9: Rozpočet Ministerstva zdravotníctva podľa programov"]
[null,"Program","Suma v eur"]
[null,"Prevencia a ochrana zdravia",312073.15999999997]
[null,"Zdravotná starostlivosť",11136103.92]
[null,"Tvorba a implementácia politík",4273844.17]
[null,"Realizácia II. etapy implementácie Medzinárodných zdravotných predpisov Svetovej zdravotníckej organizácie v SR",49200]
[null,"Informačné technológie financované zo štátneho rozpočtu",63870]
[null,"Zdroj: MZ[1]"]
[null,"[1] MZ SR. Návrh záverečného účtu MZ SR za rok 2017. http://www.health.gov.sk/Clanok?zu-mzsr-2017. "]

{"sheet":"tabuľka_10","index":10,"n_rows":7,"n_cols":10,"rows_kept":7,"cut":false,"hidden":false,"merged":[[0,1,0,9],[5,1,5,9],[6,1,6,9]]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Tabuľka 10: Rozpočet v zdravotníctve (mil. eur)"]
[null,"Rozpočtová organizácia"," 2015 S*","2016 S","2017 S","2018 R*","2018 OS*","2019 N","2020 N ","2021 N"]
[null,"Ministerstvo zdravotníctva",57,69,80,143,116,181,152,152]
[null,"Verejné zdravotné poistenie",4214,4539,4576,4711,4817,4931,5045,5201]
[null,"VZP/ MZ SR",74,66,57,33,42,27,33,34]
[null,"*S – skutočnosť, OS – očakávaná skutočnosť, N - návrh"]
[null,"Zdroj: Príloha 1 k RVS a RVS 2018 - 2020 schválený NR SR"]

{"sheet":"tabuľka_11","index":11,"n_rows":30,"n_cols":8,"rows_kept":30,"cut":false,"hidden":false,"merged":[[2,5,4,5],[2,6,4,6],[2,7,4,7],[0,1,0,7],[29,1,29,7],[6,1,7,1],[8,1,28,1],[2,1,5,1],[2,2,4,2],[2,3,4,3],[2,4,4,4]]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Tabuľka 11: Príklad programovej štruktúry – program Ústavná zdravotná starostlivosť"]
[null,"Program","Ústavná zdravotná starostlivosť ",2017,2018,2019,2020,2021]
[null,"Ciele","Zvyšovanie kvality poskytovanej ZS pomocou koncentrácie výkonov o 5%"]
[]
[]
[null,null,"Znižovanie dĺžky hospitalizácie v súlade so schválenou stratifikáciou nemocníc"]
[null,"Nástroje","Stratifikácia siete nemocníc (časť 5.2.1)"]
[null,null,"Úprava spôsobu odmeňovania personálu "]
[null,"Merateľné ukazovatele","Celkové náklady ústavnej zdravotnej starostlivosti v mil. eur"]
[null,null,"Plán"]
[null,null,"Skutočnosť"]
[null,null,"EBITDA v mil. eur"]
[null,null,"Plán"]
[null,null,"Skutočnosť"]
[null,null,"Záväzky po lehote splatnosti v mil. eur"]
[null,null,"Plán"]
[null,null,"Skutočnosť"]
[null,null,"Priemerná dĺžka hospitalizácie v dňoch"]
[null,null,"Plán"]
[null,null,"Skutočnosť"]
[null,null,"Počet lekárov (na 1 000 obyvateľov)"]
[null,null,"Plán"]
[null,null,"Skutočnosť"]
[null,null,"Počet sestier (na 1 000 obyvateľov)"]
[null,null,"Plán"]
[null,null,"Skutočnosť"]
[null,null,"Výška kapitálových výdavkov v mil. eur"]
[null,null,"Plán"]
[null,null,"Skutočnosť"]
[null,"Zdroj: Predbežný návrh ÚHP a IJ"]

{"sheet":"tabuľka_12","index":12,"n_rows":8,"n_cols":5,"rows_kept":8,"cut":false,"hidden":false,"merged":[[6,1,6,4],[7,1,7,4]]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Tabuľka 12: Skutočne vybrané zdroje v zdravotníctve (mil. eur)"]
[null,null,2015,2016,2017]
[null,"Vybrané zdroje spolu",4290,4394,4641]
[null,"príjmy od EAO (vrátane RZZP)",2880,2953,3292]
[null,"príjmy za poistencov štátu (vrátane RZ)",1349,1392,1299]
[null,"ostatné príjmy VZP ",61,49,50]
[null,"Pozn.: EAO – ekonomicky aktívne osoby, RZZP – ročné zúčtovanie zdravotného poistenia, RZ – ročné zúčtovanie"]
[null,"Zdroj: Návrh záverečného účtu MZ SR 2017"]

{"sheet":"tabuľka_13","index":13,"n_rows":5,"n_cols":3,"rows_kept":5,"cut":false,"hidden":false,"merged":[[0,1,0,2],[4,1,4,2]]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Tabuľka 13: Zmeny výdavkov - VZP - súhrn"]
[null,"mil. eur",2019]
[null,"Zmeny spolu (oproti rozpočtu 2018)",219]
[null,"Zmeny spolu (oproti rozpočtu 2018; %)",4.7E-2]
[null,"Zdroj: Návrh RVS 2019 - 2021 schválený vládou"]

{"sheet":"tabuľka_14","index":14,"n_rows":14,"n_cols":5,"rows_kept":14,"cut":false,"hidden":false,"merged":[[14,1,14,2],[0,1,0,4],[13,1,13,4],[11,2,11,3]]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Tabuľka 14: Zmeny výdavkov - VZP - bez zmien politík"]
[null,"č.","mil. eur",null,2019]
[null,null,"Spolu",null,131]
[null,1,"  Nemzdové (rast o CPI)",null,29]
[null,null,"  Mzdové",null,96]
[null,2,"    Automat lekári ÚZS",null,23]
[null,3,"    Automat ostatní ÚZS + MM*",null,36]
[null,4,"    Nezdravotnícki zamestnanci",null,9]
[null,5,"    Ambulantní zdravotnícki zamestnanci",null,28]
[null,null,"  Iné výdavky VZP",null,-17]
[null,6,"    Správa ZP, príspevky na UDZS, OS ZZS, NCZI, iné úhrady",null,-17]
[null,7,"Starnutie",null,23]
[null,"*MM – minimálna mzda"]
[null,"Zdroj: Návrh RVS 2019 - 2021 schválený vládou"]

{"sheet":"tabuľka_15","index":15,"n_rows":21,"n_cols":4,"rows_kept":21,"cut":false,"hidden":false,"merged":[[19,1,19,3],[20,1,20,3]]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Tabuľka 15: Zmeny výdavkov - VZP - zmeny politík"]
[null,"č.","mil. eur",2019]
[null,null,"Spolu",180]
[null,null,"Hodnotové opatrenia - Hodnota za peniaze",87]
[null,8,"    Rast miezd nelekárskeho personálu ÚZS",59]
[null,9,"    Rast miezd nelekárskeho personálu AZS",18]
[null,10,"    Prevencia - skríningy",5]
[null,11,"    Zazmluvnenie nových SVLZ poskytovateľov*",0]
[null,12,"    Zmena financovania RTG",5]
[null,null,"Ostatné zmeny politík",93]
[null,13,"    Rast príplatkov za prácu v noci, cez víkendy a sviatky",24]
[null,14,"    Lieky - novela 363/2011",56]
[null,15,"    Ochranný limit doplatkov*",0]
[null,16,"    Dofinancovanie VšZP pre nemocnice*",0]
[null,17,"    Dofinancovanie nákladov ambulancií so zavedením e-Health a bonusy za jeho využívanie",2]
[null,18,"    Urgenty - paušály",7]
[null,19,"    ZZS - paušály",1]
[null,20,"    Dlhodobá starostlivosť",0]
[null,21,"    Nárast liečby v cudzine",3]
[null,"Pozn.: * - opatrenie s vplyvom v roku 2018"]
[null,"Zdroj: Návrh RVS 2019 - 2021 schválený vládou"]

{"sheet":"tabuľka_16","index":16,"n_rows":8,"n_cols":4,"rows_kept":8,"cut":false,"hidden":false,"merged":[[7,1,7,3]]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Tabuľka 16: Zmeny výdavkov - VZP - úsporné opatrenia - Hodnota za peniaze (mil. eur)"]
[null,"č.",null,2019]
[null,null,"Spolu",-92]
[null,22,"    Revízia úhrad kategorizovaných liekov",-50]
[null,23,"    Lieky - variabilita v predpisovaní, vplyv e-preskripcie",-30]
[null,24,"    Výnimky na lieky - zavedenie pravidiel pre preplácanie výnimiek",-8]
[null,25,"    Zdravotnícke pomôcky – externé referencovanie a revízne činnosti",-4]
[null,"Zdroj: Návrh RVS 2019 - 2021 schválený vládou"]

{"sheet":"tabuľka_17","index":17,"n_rows":11,"n_cols":4,"rows_kept":11,"cut":false,"hidden":false,"merged":[[10,1,10,3]]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Tabuľka 17: Zmeny výdavkov – nemocnice (mil. eur)"]
[null,"č.",null,2019]
[null,null,"  Úsporné opatrenia",-46]
[null,26,"    Optimalizácia prevádzkových nákladov",-5]
[null,27,"    Optimalizácia procesov ÚZS",-32]
[null,28,"    Optimalizácia nákupu liekov a ŠZM[1]",-1]
[null,29,"    ŠZM - zníženie cien - externé referencovanie",0]
[null,30,"    ŠZM - referencovanie kategorizovaného ŠZM",-8]
[null,31,"    ŠZM - zavedenie základného funkčného typu",0]
[null,"[1]  ŠZM predstavuje invazívne zdravotnícke pomôcky, ktoré sa používajú takmer výlučne v ústavnej zdravotnej starostlivosti."]
[null,"Zdroj: Návrh RVS 2019 - 2021 schválený vládou"]

{"sheet":"tabuľka_18","index":18,"n_rows":8,"n_cols":2,"rows_kept":8,"cut":false,"hidden":false,"merged":[]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Tabuľka 18: Opatrenia s ďalším potenciálom pre zefektívnenie"]
[null,"Centrálny nákup liekov a zmluvy o zdieľaní rizika a nákladov"]
[null,"Možnosti potenciálne nákladovo neefektívnych liekov"]
[null,"Zníženie jednotkových cien a limitov vyšetrení"]
[null,"Variabilita v predpisovaní vyšetrení"]
[null,"Zlepšenie revíznych činností VšZP"]
[null,"Úprava stanovenia výdavkov správneho fondu"]
[null,"Zdroj: Návrh RVS 2019 - 2021 schválený vládou"]

{"sheet":"tabuľka_19","index":19,"n_rows":18,"n_cols":7,"rows_kept":18,"cut":false,"hidden":false,"merged":[[0,1,0,6],[17,1,17,6]]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Tabuľka 19: Výdavky VZP v štruktúre navrhovaných programov, mil. eur"]
[null,"mil. eur","2016 S","2017 S","2018 R","2018 OS","2019 N"]
[null,"Zdravotná starostlivosť ",4300,4341,4467,4494,4704]
[null,"Lieky a dietetické potraviny",1060,1070,1101,1107,1069]
[null,"Zdravotnícke pomôcky a ŠZM",186,188,194,195,190]
[null,"ÚZS (lôžka)",1264,1276,1313,1321,1466]
[null,"VAS",233,235,242,243,256]
[null,"SVLZ",491,495,510,513,527]
[null,"ŠAS",802,809,833,838,877]
[null,"Pohotovostná služba PP",15,16,16,16,17]
[null,"Záchr. zdravotná služba",86,87,89,90,96]
[null,"Kúpeľná starostlivosť",52,52,54,54,56]
[null,"Doprava",26,26,27,27,27]
[null,"Vrtuľníková záchr. služba",11,11,12,12,12]
[null,"   Ostatné subjekty a iná ZS",75,76,78,78,111]
[null,"Iné výdavky VZP",239,235,244,323,227]
[null,"VZP spolu",4539,4576,4711,4817,4931]
[null,"Zdroj: Návrh RVS 2019 - 2021 schválený vládou"]

{"sheet":"tabuľka_20","index":20,"n_rows":10,"n_cols":4,"rows_kept":10,"cut":false,"hidden":false,"merged":[[9,1,9,3],[0,1,0,3],[1,2,2,2],[1,3,2,3]]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Tabuľka 20: Prehľad minimálnych objemov vybraných výkonov podľa Leapfrog group"]
[null,"Výkon","Minimálny počet  (the Leapfrog Group)","Minimálny počet (Iné krajiny)"]
[]
[null,"Resekcia – rakovina pažeráka",20,"10 (Nemecko)"]
[null,null,null,"20 (Holandsko)"]
[null,"Operácia – rakovina konečníka",16]
[null,"Operácia – rakovina pankreasu",20,"10 (Nemecko) "]
[null,null,null,"20 (Holandsko)"]
[null,"Operácia – rakovina pľúc",40,"20 (Holandsko)"]
[null,"Zdroj: Štúdia MZ SR a Svetovej Banky – Minimal Volume Threshold"]

{"sheet":"tabuľka_21","index":21,"n_rows":16,"n_cols":5,"rows_kept":16,"cut":false,"hidden":false,"merged":[[15,1,15,4],[9,1,11,1],[12,2,14,2],[3,1,5,1],[3,2,5,2],[12,4,14,4],[9,4,11,4],[12,1,14,1],[9,2,11,2],[9,3,11,3],[12,3,14,3],[3,4,5,4],[6,3,8,3],[3,3,5,3],[0,1,0,4],[1,2,2,2],[1,3,2,3],[1,4,2,4],[6,2,8,2],[6,1,8,1]]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Tabuľka 21: Rozdelenie nemocníc podľa ZS"]
[null,"Úroveň ZS","Základná ZS","Regionálna ZS","Národná ZS"]
[null,"Typ nemocnice"]
[null,"Lokálna nemocnica","musí poskytovať","môže poskytovať, ak splní štandardy","nemôže poskytovať"]
[]
[]
[null,"Regionálna\nnemocnica\n","musí poskytovať, ale v pomerne menšej miere\n","musí poskytovať aspoň jednu špecializáciu","môže poskytovať,"]
[]
[null,null,null,null,"ak splní štandardy"]
[null,"Národná nemocnica","musí poskytovať, ale v pomerne menšej miere","musí poskytovať, ale v pomerne menšej miere","musí poskytovať aspoň jednu špecializáciu"]
[]
[]
[null,"Geografické rozloženie","dostupnosť do 30 minút\n45 spádových oblastí\n","dostupnosť do 60 minút\n10 spádových oblastí\n","dostupnosť do 120 minút\n3 spádové oblasti"]
[]
[]
[null,"Zdroj: Štúdia k stratifikácii nemocníc MZ"]

{"sheet":"tabuľka_22","index":22,"n_rows":14,"n_cols":3,"rows_kept":14,"cut":false,"hidden":false,"merged":[[0,1,0,2],[13,1,13,2],[12,1,12,2]]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Tabuľka 22: Údaje o skríningu karcinómu kolorekta, 2017"]
[null,"Štatistiky z dát zdravotných poisťovní z roku 2017","Hodnota"]
[null,"Počet ľudí vo veku 50-75",1625413]
[null,"Priemerný počet vyšetrení na test krvi v stolici za rok",249694]
[null,"Jednotková cena skríningového testu krvi v stolici",11]
[null,"V prípade pozitívneho výsledku, podstúpi kolonoskopiu z pôvodného počtu pacientov testovaných na krv v stolici ",0.06]
[null,"Priemerná cena kolonoskopického vyšetrenia",82]
[null,"Z realizovaných kolonoskopií má pozitívny nález",0.2]
[null,"Výskyt ochorenia ročný",3011]
[null,"Ročná mortalita na diagnózu C18, C19, C20, C21*",2000]
[null,"Počet liečených pacientov ročne",8700]
[null,"Ročné náklady na liečbu 1 pacienta",7000]
[null,"*C18 – zhubný nádor hrubého čreva, C19 – zhubný nádor rektorsigmoidového spojenia, C20 – zhubný nádor konečníka, C21 – zhubný nádor anusu a análneho kanála"]
[null,"Zdroj: MZ SR"]

{"sheet":"tabuľka_23","index":23,"n_rows":15,"n_cols":3,"rows_kept":15,"cut":false,"hidden":false,"merged":[[0,1,0,2]]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Tabuľka 23: Výpočet dopadu rozšírenia skríningu rakoviny kolorekta"]
[null,"Modelovanie nákladov a prínosov opatrenia na obdobie 1 roka","Hodnota"]
[null,"Počet ľudí, ktorí podstúpia dodatočne skríning oproti súčasnému stavu",156660]
[null,"Dodatočné náklady pri navýšení počtu testov na krv v stolici na 50% populácie, vek 50+",-1723255]
[null,"Následné dodatočné náklady na kolonoskopiu",-776036]
[null,"Administratívne náklady spojené so zvolávaním na vyšetrenie (0,4 €/obyv.)",-225205]
[null,"Marginálný výskyt ochorenia, zreálnená na 50%",945]
[null,"Marginálne náklady na liečbu novodiagnostikovaných pacientov s predpokladom včasného zachytenia karcinómu kolorekta len v 1. alebo 2. štádiu",-2267176]
[null,"Celkové marginálne náklady na opatrenie",-4991671]
[null,"Náklady na liečbu ak by títo pacienti podstúpili diagnostiku podľa NPC",-6612597]
[null,"Čistý finančný prínos rozsiahlejšej diagnostiky na nižšie náklady liečby",1620926]
[null,"Počet odvrátených úmrtí podľa scenára vyrovnania priemeru mortality krajín EU (z 37 na 30 úmrtí /100tis. ob. od roku 2020)",362]
[null,"Hodnota 1 odvráteného úmrtia",40918]
[null,"Celkový čistý spoločenský prínos opatrenia ",16433242]
[null,null,"Zdroj: MZ SR"]

{"sheet":"tabuľka_24","index":24,"n_rows":7,"n_cols":5,"rows_kept":7,"cut":false,"hidden":false,"merged":[[1,1,2,1],[1,2,1,4],[6,1,6,4]]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Tabuľka 24: Vývoj úhrad zdravotných poisťovní za lieky na výnimky"]
[null,null,"1. polrok"]
[null,null,2016,2017,2018]
[null,"Celková úhrada poisťovní za lieky na výnimky, eur",19156870,19008416,18816587]
[null,"Medziročná zmena v absolútnom vyjadrení, eur",null,-148454,-191829]
[null,"Medziročná zmena v, %",null,-0.01,-0.01]
[null,"Zdroj: ZP, prepočty Implementačná jednotka (IJ)"]

{"sheet":"tabuľka_25","index":25,"n_rows":9,"n_cols":6,"rows_kept":9,"cut":false,"hidden":false,"merged":[[0,1,0,5],[4,5,6,5],[7,1,7,5],[8,1,8,5],[4,1,6,1],[4,3,6,3],[4,4,6,4],[4,2,6,2]]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Tabuľka 25: Prehľad HTA* limitov k 1.1.2018"]
[null," ","Veľká Británia","Poľsko","Maďarsko","Slovensko"]
[null,"Dolný limit (EUR/QALY) ",22.408000000000001,22.991,"- ",31.92]
[null,"Horný limit (EUR/QALY) ",33.612000000000002,34.487000000000002,34.741,37.392000000000003]
[null,"Špeciálny limit (EUR/QALY) ","56,021* ","- ","- ","Lieky na zriedkavé ochorenia nemajú limit"]
[]
[]
[null,"*lieky pre pacientov v záverečnej fáze života"]
[null,"Zdroj: MZ SR"]

{"sheet":"tabuľka_26","index":26,"n_rows":40,"n_cols":10,"rows_kept":40,"cut":false,"hidden":false,"merged":[[32,1,35,1],[32,2,35,2],[36,1,39,1],[36,2,39,2],[1,3,2,3],[8,2,11,2],[12,1,15,1],[12,2,15,2],[16,1,19,1],[16,2,19,2],[24,1,27,1],[24,2,27,2],[28,1,31,1],[28,2,31,2],[4,1,7,1],[4,2,7,2],[8,1,11,1],[20,1,23,1],[20,2,23,2],[0,1,0,9],[1,1,2,1],[1,2,2,2],[1,4,2,4],[1,5,2,5],[1,6,2,6],[1,7,2,7],[1,8,2,8],[1,9,2,9]]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Tabuľka 26: Výsledky v zdravotníctve - úroveň hodnotenia 1: zdravotný stav obyvateľstva"]
[null,"Ukazovateľ","Zdroj","SK/Benchmark",2011,2012,2013,2014,2015,2016]
[]
[]
[null,"Úmrtnosť odvrátiteľná systémom zdravotnej starostlivosti (na 100 000 obyvateľov)","Eurostat","SK",262.2,260.60000000000002,261.5,242.8,250,"-"]
[null,null,null,"V3",227.3,222.4,215.8,204.2,205.2,"-"]
[null,null,null,"EÚ28",169,165.4,159.80000000000001,152.80000000000001,153.5,"-"]
[null,null,null,"EÚ15",0,0,0,0,0,"-"]
[null,"Potenciálne stratené roky života z predchádzateľných príčin, ženy (na 100 000 obyvateľov)","OECD","SK","-",2916,2969,2855,"-","-"]
[null,null,null,"V3",3035,2958,2846,2750,2747,2686]
[null,null,null,"EÚ28",2464,2406,2370,2271,2259,2448]
[null,null,null,"EÚ15",2130,2068,2027,1955,1918,1943]
[null,"Očakávaná dĺžka života pri narodení, ženy","OECD","SK",79.8,79.900000000000006,80.099999999999994,80.5,80.2,80.7]
[null,null,null,"V3",80.3,80.3,80.5,81,80.7,81.3]
[null,null,null,"EÚ28",82.6,82.6,82.8,83.2,82.9,83.1]
[null,null,null,"EÚ15",83.7,83.6,83.9,84.3,84,84.2]
[null,"Úmrtnosť na choroby obehovej sústavy, štandardizovaná (na 100 tis. obyv.)","OECD","SK","-",436.3,445.7,422.4,"-","-"]
[null,null,null,"V3",531,539.4,531.70000000000005,515,541.20000000000005,545.5]
[null,null,null,"EÚ28",394.1,403.6,398.6,389.3,424.2,470.4]
[null,null,null,"EÚ15",305.89999999999998,310.5,302.10000000000002,294,318.10000000000002,308.7]
[null,"Úmrtnosť na nádory, štandardizovaná (na 100 tis. obyv.)","OECD","SK","-",237.3,247.1,249.9,"-","-"]
[null,null,null,"V3",276.2,281.3,278.7,280.10000000000002,284.2,297.10000000000002]
[null,null,null,"EÚ28",252.9,254.3,254.1,256.2,263.10000000000002,267.3]
[null,null,null,"EÚ15",241.8,243.3,241.8,243.7,247.8,241.3]
[null,"Prevalencia obezity (%) podiel u dospelých","OECD","SK","-","-","-",54.2,"-","-"]
[null,null,null,"V3","-","-","-",54.4,"-","-"]
[null,null,null,"EÚ28",48.8,47.5,48,51.2,50,51]
[null,null,null,"EÚ15",48.8,47,48,49.6,50,50.8]
[null,"Prevalencia vysokého tlaku (%) podiel u dospelých","Eurostat","SK","-","-","-",25.8,"-","-"]
[null,null,null,"V3","-","-","-",26.2,"-","-"]
[null,null,null,"EÚ28","-","-","-",21.5,"-","-"]
[null,null,null,"EÚ15","-","-","-",19.3,"-","-"]
[null,"Prevalencia chronickej depresie (%) populácie","Eurostat","SK","-","-","-",4.2,"-","-"]
[null,null,null,"V3","-","-","-",4.3,"-","-"]
[null,null,null,"EÚ28","-","-","-",7.5,"-","-"]
[null,null,null,"EÚ15","-","-","-",8.5,"-","-"]
[null,"Dojčenská úmrtnosť na 1 000 živonarodených","OECD","SK",4.9000000000000004,5.8,5.5,5.8,5.0999999999999996,5.4]
[null,null,null,"V3",4.0999999999999996,4,4,3.7,3.6,3.6]
[null,null,null,"EÚ28",3.7,3.5,3.5,3.3,3.3,3.3]
[null,null,null,"EÚ15",3.3,3.2,3.3,3.2,3.1,3.2]

{"sheet":"tabuľka_27","index":27,"n_rows":12,"n_cols":11,"rows_kept":12,"cut":false,"hidden":false,"merged":[[7,1,10,1],[7,2,10,2],[7,8,10,8],[7,9,10,9],[7,10,10,10],[1,10,2,10],[3,1,6,1],[3,2,6,2],[3,8,6,8],[3,9,6,9],[3,10,6,10],[0,1,0,9],[1,1,2,1],[1,2,1,7],[1,8,2,8],[1,9,2,9]]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Tabuľka 27: Lieky a zdravotnícke pomôcky"]
[null,"Ukazovateľ","Porovnanie",null,null,null,null,null,"Zámer","Dopad na zdravie","Iné prínosy"]
[null,null,"Zdroj","Krajiny",2013,2014,2015,2016]
[null,"Spotreba liekov (DDD na 1 000 obyv.)","OECD","SK",1812.2,1861.2,1909.3,1600.4,"Zníženie spotreby","Predchádzanie kontraindikáciám a liekovým interakciám","Šetrenie zdrojov, ak zvýšenú spotrebu spôsobuje duplicitné predpisovanie"]
[null,null,null,"V3",1570,1608.6,1650.4,1670.4]
[null,null,null,"EU-28",1291.5,1314.1,1339.3,1343.7]
[null,null,null,"EU-15",1295.0999999999999,1313.6,1335.8,1361.8]
[null,"Spotreba antibiotík (DDD na 1 000 obyv.)","OECD","SK",25.9,24.8,26.8,21.6,"Zníženie spotreby","Zníženie rezistencie voči antibiotikám, zvýšenie šance na úspešnú liečbu"," -"]
[null,null,null,"V3",19.399999999999999,19.3,20.6,19]
[null,null,null,"EU-28",20.399999999999999,20,20.6,19.899999999999999]
[null,null,null,"EU-15",21.5,21.3,21.6,21.4]
[null,"Podiel generík na spotrebe liekov","OECD","SK",69.599999999999994,69.3,67.599999999999994,64.900000000000006,"Rast podielu na spotrebe"," -","Šetrenie zdrojov pacienta – zvýšenie ekonomickej dostupnosti"]

{"sheet":"tabuľka_28","index":28,"n_rows":11,"n_cols":8,"rows_kept":11,"cut":false,"hidden":false,"merged":[[10,1,10,7]]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Tabuľka 28: Prehľad počtu liekov a objemu úhrad ZP podľa spôsobu stanovenia úhrad"]
[null,null,null,"počet liekov","podiel z počtu liekov ","úhrada, mil. eur","podiel z úhrady","možná úspora, mil. eur"]
[]
[null,1,"zoskupenie do porovnateľnej ref. skupiny (§ 6 odsek 2 vyhlášky 435/2011)",2489,0.56999999999999995,748,0.68,64]
[null,2,"zoskupenie do úhradovej skupiny (§ 2 písmeno b, § 5 vyhlášky 435/2011)",836,0.19,137,0.12,0]
[null,3,"zoskupenie do špecifickej skupiny (§ 8 vyhlášky 435/2011)",149,0.03,15,0.01,"-"]
[null,4,"či je liek určený na povinné očkovanie (§ 7 zákona 363/2011)",261,0.06,55,0.05,"-"]
[null,5,"či má liek predĺžené uvoľňovanie (§ 8 zákona 363/2011)",569,0.13,113,0.1,"-"]
[null,6,"či ide o kombináciu liečiv (§ 9 zákona 363/2011)",54,0.01,31,0.03,"-"]
[null,"* Platí pre všetky lieky, ak nespadajú pod žiadny z bodov 2 – 6.                                      "]
[null,"  Zdroj: kategorizácia, NCZI, výpočty ÚHP"]

{"sheet":"graf_1","index":29,"n_rows":10,"n_cols":7,"rows_kept":10,"cut":false,"hidden":false,"merged":[]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Graf 1: Odvrátiteľná úmrtnosť (na 100 000 obyvateľov)"]
[null,"Zdroj: Eurostat, Amenable and preventable deaths of residents [hlth_cd_apr]"]
[null,"http://ec.europa.eu/eurostat/web/lfs/data/database"]
[null,null,2011,2012,2013,2014,2015]
[null,"SK",262.16000000000003,260.56,261.54000000000002,242.83,249.96]
[null,"V3",227.28666666666666,222.44000000000003,215.80000000000004,204.20333333333335,205.22666666666666]
[null,"EU 28",169.01555555555555,165.35925925925926,159.77555555555554,152.75481481481478,153.45703703703705]
[null,"EU 15",112.00999999999999,109.52600000000002,106.98399999999999,101.87666666666668,102.06666666666666]
[null,"aktualizované 22.11.2017"]
[null,"štandardizovaná miera úmrtí na 100 tis obyvateľov"]

{"sheet":"graf_2","index":30,"n_rows":10,"n_cols":19,"rows_kept":10,"cut":false,"hidden":false,"merged":[]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Graf 2: Očakávaná dĺžka života žien pri narodení"]
[null,"Zdroj: OECD - Health-Health status - Life expectancy - Females at birth"]
[null,"http://stats.oecd.org/"]
[null,null,2000,2001,2002,2003,2004,2005,2006,2007,2008,2009,2010,2011,2012,2013,2014,2015,2016]
[null,"SK",77.5,77.7,77.7,77.7,78,78.099999999999994,78.400000000000006,78.400000000000006,79,79.099999999999994,79.3,79.8,79.900000000000006,80.099999999999994,80.5,80.2,80.7]
[null,"V3",77.566666666666663,77.86666666666666,78.066666666666663,78.033333333333346,78.5,78.566666666666663,79.133333333333326,79.266666666666666,79.600000000000009,79.666666666666671,80.066666666666663,80.3,80.333333333333329,80.533333333333317,81.033333333333346,80.733333333333334,81.266666666666666]
[null,"EU28",80.068181818181827,80.318181818181841,80.243478260869566,80.226086956521726,80.817391304347836,80.882608695652166,81.278260869565216,81.421739130434787,81.75217391304345,82.004347826086956,82.282608695652158,82.578260869565199,82.556521739130417,82.77391304347826,83.191304347826105,82.926086956521743,83.13636363636364]
[null,"EU15",81.173333333333332,81.426666666666677,81.52,81.5,82.186666666666667,82.24666666666667,82.653333333333336,82.813333333333333,83.02,83.24,83.47999999999999,83.726666666666659,83.639999999999972,83.886666666666684,84.286666666666676,83.973333333333329,84.164285714285711]
[null,"OECD",80.157142857142873,80.451428571428551,80.441666666666663,80.5,81.002777777777794,81.105555555555554,81.433333333333337,81.577777777777797,81.869444444444426,82.102777777777774,82.333333333333314,82.577777777777783,82.6,82.899999999999991,83.249999999999972,83.074999999999989,83.24848484848485]
[null,"Údaje sú uvedené v rokoch"]

{"sheet":"graf_3","index":31,"n_rows":8,"n_cols":4,"rows_kept":8,"cut":false,"hidden":false,"merged":[]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Graf 3: Počet lekárov (na 1 000 obyv.), 2017"]
[null,"Zdroj: OECD - Health - Health Care resources - Physicians "]
[null,"http://stats.oecd.org/"]
[null,null,2000,2015]
[null,"SK",3.35,3.45]
[null,"V3",2.7566666666666673,3.0400000000000005]
[null,"EU-28",2.9905000000000004,3.6386956521739138]
[null,"EU-15",3.0333333333333337,3.8220000000000001]

{"sheet":"graf_4","index":32,"n_rows":8,"n_cols":8,"rows_kept":8,"cut":false,"hidden":false,"merged":[]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Graf 4: Počet lekárov podľa špecializácií (na 1 000 obyv.), 2016*"]
[null,"Zdroj: OECD - Health - Health Care resources - Physicians by categories"]
[null,"http://stats.oecd.org/"]
[null,null,"Všeobecný","Pediater","Gyn. a pôr.","Psychiater","Chirurg","Špecialista "]
[null,"SK",0.4,0.2,0.2,0.1,0.8,1.5]
[null,"V3",0.42,0.15,0.14000000000000001,0.09,0.57999999999999996,1.61]
[null,"EU28",1.0900000000000001,0.19,0.17,0.18,0.79,1.91]
[null,"EU15",1.24,0.18,0.16,0.19,0.8,1.91]

{"sheet":"graf_5","index":33,"n_rows":8,"n_cols":4,"rows_kept":8,"cut":false,"hidden":false,"merged":[]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Graf 5: Počet zdravotných sestier (na 1 000 obyv.), 2000 a 2015"]
[null,"Zdroj: OECD - Health - Health Care resources - Practising nurses"]
[null,"http://stats.oecd.org/"]
[null,null,2000,2015]
[null,"SK",7.44,5.7]
[null,"V3",5.95,6.56]
[null,"EU-28",7.3247368421052625,8.6769565217391289]
[null,"EU-15",8.089090909090908,9.8039999999999985]

{"sheet":"graf_6","index":34,"n_rows":19,"n_cols":3,"rows_kept":19,"cut":false,"hidden":false,"merged":[]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Graf 6: Počet zdravotných sestier (Practising nurses, na 1 000 obyv.), 2016* "]
[null,"Zdroj: OECD - Health - Health Care resources - Practising nurses"]
[null,"http://stats.oecd.org/"]
[null,null,2016]
[null,"BE",11.13]
[null,"EE",6.1]
[null,"DE",12.85]
[null,"HU",6.44]
[null,"IT",5.57]
[null,"LV",4.6399999999999997]
[null,"LT",7.7]
[null,"NL",10.58]
[null,"PL",5.16]
[null,"SK",5.75]
[null,"SI",9.65]
[null,"ES",5.51]
[null,"UK",7.88]
[null,"Priemer EU*",7.77]
[null,"* Priemer krajín EÚ s porovnateľným vykazovaním počtu zdravotných sestier"]

{"sheet":"graf_7","index":35,"n_rows":14,"n_cols":4,"rows_kept":14,"cut":false,"hidden":false,"merged":[]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Graf 7: Veková štruktúra, lekári a sestry, 2016"]
[null,"Zdroj: NCZI"]
[null,null,"lekár","sestra"]
[null,"0-19",0,0]
[null,"20-24",72,776]
[null,"25-29",2021,1467]
[null,"30-34",2171,2438]
[null,"35-39",1637,4131]
[null,"40-44",2225,6410]
[null,"45-49",2277,4691]
[null,"50-54",1681,4457]
[null,"55-59",1901,4310]
[null,"60-64",2702,1856]
[null,"65+",2177,647]

{"sheet":"graf_8","index":36,"n_rows":8,"n_cols":7,"rows_kept":8,"cut":false,"hidden":false,"merged":[]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Graf 8: Veková štruktúra, lekári podľa špecializácií (%), 2016"]
[null,"Zdroj: Slovenská lekárska komora"]
[null,null,"20-30","30-40","40-50","50-60","60+"]
[null,"Všeobecný",0.3115264797507788,8.3667111704494879,21.050289274588341,27.325322652425456,42.946150422785941]
[null,"Pediater",0.74349442379182151,10.532837670384138,21.623296158612142,25.712515489467165,41.38785625774473]
[null,"Špecialista",0.56721551069721188,16.770671932947565,28.682103121670561,23.662340387918686,30.317669046765971]
[null,"Chirurg",0,14.492753623188406,28.985507246376812,33.333333333333329,23.188405797101449]
[null,"Psychiater",0.30674846625766872,19.325153374233128,40.030674846625772,13.036809815950919,27.300613496932513]

{"sheet":"graf_9","index":37,"n_rows":36,"n_cols":4,"rows_kept":36,"cut":false,"hidden":false,"merged":[]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Graf 9: Verejné výdavky na lieky* na osobu, bežné ceny, EUR, 2016"]
[null,"Zdroj: OECD - Health - Health expenditure and financing - Pharmaceuticals and other"]
[null,"https://stats.oecd.org/"]
[null,null,null,2016]
[null,"Switzerland",{"$f":"VLOOKUP(B5,[1]slovník!$A$14:$D$51,4,0)","v":"CH"},674.19082568807335]
[null,"Germany",{"$f":"VLOOKUP(B6,[1]slovník!$A$14:$D$51,4,0)","v":"DE"},511.24099999999999]
[null,"Luxembourg",{"$f":"VLOOKUP(B7,[1]slovník!$A$14:$D$51,4,0)","v":"LU"},425.21199999999999]
[null,"Ireland",{"$f":"VLOOKUP(B8,[1]slovník!$A$14:$D$51,4,0)","v":"IE"},423.84500000000003]
[null,"France",{"$f":"VLOOKUP(B9,[1]slovník!$A$14:$D$51,4,0)","v":"FR"},405.512]
[null,"Belgium",{"$f":"VLOOKUP(B10,[1]slovník!$A$14:$D$51,4,0)","v":"BE"},384.53899999999999]
[null,"Austria",{"$f":"VLOOKUP(B11,[1]slovník!$A$14:$D$51,4,0)","v":"AT"},342.60500000000002]
[null,"Norway",{"$f":"VLOOKUP(B12,[1]slovník!$A$14:$D$51,4,0)","v":"NO"},288.8930147454526]
[null,"United Kingdom",{"$f":"VLOOKUP(B13,[1]slovník!$A$14:$D$51,4,0)","v":"UK"},284.35042735042737]
[null,"Italy",{"$f":"VLOOKUP(B14,[1]slovník!$A$14:$D$51,4,0)","v":"IT"},275.12299999999999]
[null,"EU15","EU15",274.29154641478044]
[null,"Sweden",{"$f":"VLOOKUP(B16,[1]slovník!$A$14:$D$51,4,0)","v":"SE"},262.74537965994301]
[null,"Canada","CA",257.62073669849934]
[null,"Finland",{"$f":"VLOOKUP(B18,[1]slovník!$A$14:$D$51,4,0)","v":"FI"},256.947]
[null,"OECD","OECD",253.60777003840485]
[null,"EU28","EU28",235.39786932708952]
[null,"Spain",{"$f":"VLOOKUP(B21,[1]slovník!$A$14:$D$51,4,0)","v":"ES"},233.905]
[null,"Netherlands",{"$f":"VLOOKUP(B22,[1]slovník!$A$14:$D$51,4,0)","v":"NL"},223.91]
[null,"Korea","KR",212.55421938184728]
[null,"Slovak Republic","SK",197.82]
[null,"Greece",{"$f":"VLOOKUP(B25,[1]slovník!$A$14:$D$51,4,0)","v":"EL"},188.595]
[null,"Slovenia",{"$f":"VLOOKUP(B26,[1]slovník!$A$14:$D$51,4,0)","v":"SI"},151.815]
[null,"Denmark",{"$f":"VLOOKUP(B27,[1]slovník!$A$14:$D$51,4,0)","v":"DK"},144.70624580255205]
[null,"Portugal",{"$f":"VLOOKUP(B28,[1]slovník!$A$14:$D$51,4,0)","v":"PT"},132.982]
[null,"Hungary",{"$f":"VLOOKUP(B29,[1]slovník!$A$14:$D$51,4,0)","v":"HU"},124.45519172355333]
[null,"Czech Republic",{"$f":"VLOOKUP(B30,[1]slovník!$A$14:$D$51,4,0)","v":"CZ"},122.50628837759858]
[null,"Estonia",{"$f":"VLOOKUP(B31,[1]slovník!$A$14:$D$51,4,0)","v":"EE"},110.111]
[null,"V3","V3",99.327980570045511]
[null,"Lithuania",{"$f":"VLOOKUP(B33,[1]slovník!$A$14:$D$51,4,0)","v":"LT"},81.165999999999997]
[null,"Latvia",{"$f":"VLOOKUP(B34,[1]slovník!$A$14:$D$51,4,0)","v":"LV"},79.037000000000006]
[null,"Poland",{"$f":"VLOOKUP(B35,[1]slovník!$A$14:$D$51,4,0)","v":"PL"},51.022461608984635]
[null,"* Výdavky na lieky zahŕňajú aj iné tovary krátkodobej spotreby, napr. obväzy a striekačky, ktoré sú na Slovensku považované za zdravotnícke pomôcky. Väčšina pomôcok spotrebovaných na Slovensku je však v databáze OECD vykazovaná v samostatnej kategórii."]

{"sheet":"graf_10","index":38,"n_rows":9,"n_cols":20,"rows_kept":9,"cut":false,"hidden":false,"merged":[]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Graf 10: Celková spotreba liekov (v denných dávkach, na 1 000 obyv.)"]
[null,"Zdroj: OECD - Health - Pharmaceutical market - Pharmaceutical consumption"]
[null,"https://stats.oecd.org/"]
[null,null,2000,2001,2002,2003,2004,2005,2006,2007,2008,2009,2010,2011,2012,2013,2014,2015,2016,"2017*"]
[null,"SK",1112.7,1197.8,1271.9000000000001,1247.8,1243.6999999999998,1349.8999999999999,1353.1000000000001,1482.8,1564.9,1624.5,1675.6000000000001,1684.1000000000001,1597.7999999999997,1812.1999999999998,1861.2000000000003,1909.3000000000002,1600.3999999999999,1552.3879999999999]
[null,"CZ",1092.4999999999998,1180,1213.2,1266.5999999999999,1278,1435.3999999999999,1322.8999999999999,1522,1430.8999999999999,1484.5,1550.1000000000001,1554,1561.3,1570.0000000000005,1608.6000000000001,1650.4,1670.4,1694.774284598594]
[null,"OECD**",989.15,1036.4666666666667,1082.1666666666667,1126.6166666666666,1179.0166666666667,1229.8333333333333,1239.95,1308.3333333333333,1244.8857142857144,1273.1857142857141,1296.7428571428572,1288.4749999999999,1311.4875,1337.5500000000002,1363.5875000000001,1394.4875000000002,1433.2857142857142,1464.1537207350182]
[null,"EU**",967.92499999999995,1011.4750000000001,1052.925,1098.9250000000002,1153.55,1213.45,1212.125,1294.6499999999999,1310.9,1328.5,1368.2500000000002,1328.54,1348.28,1360.72,1379.2800000000002,1421.2,1431.175,1452.6816128127084]
[null,"* - vývoj v roku 2017 je odhad, ** - krajiny s porovnateľným spôsobom vykazovania spotreby liekov"]

{"sheet":"graf_11","index":39,"n_rows":13,"n_cols":8,"rows_kept":13,"cut":false,"hidden":false,"merged":[]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Graf 11: Porovnanie zahraničnej a slovenskej spotreby liekov v jednotlivých ATC skupinách, 2016"]
[null,"Zdroj: NCZI"]
[null,null,"SK","CZ","EU*","OECD*","pomer SK/CZ (pravá os)","pomer SK/EU* (pravá os)"]
[null,"A Tráviaci trakt",271,283.89999999999998,249.85,278.44285714285712,0.95456146530468478,1.0846507904742846]
[null,"B Krv a krvotvor.org.",289,198.1,187.39999999999998,166.42857142857142,1.458859162039374,1.5421558164354323]
[null,"C Kardiovask. sys.",551.70000000000005,612.6,502.29999999999995,434.09999999999997,0.90058765915768857,1.098347601035238]
[null,"G Urogen.t. a pohl. horm.",59.6,101.9,75.925000000000011,81.528571428571439,0.58488714425907751,0.78498518274613094]
[null,"H Hormóny okrem pohl.",38.5,53.6,41.375,42.728571428571421,0.71828358208955223,0.93051359516616317]
[null,"J Antiinfektíva",23.3,20.7,21.625,25.24285714285714,1.1256038647342996,1.0774566473988441]
[null,"M Muskuloskel. sys.",71.5,82.8,68.774999999999991,71.899999999999991,0.86352657004830924,1.0396219556524902]
[null,"N Nervový sys.",163.80000000000001,169.9,168.5,201.44285714285712,0.96409652736904061,0.97210682492581613]
[null,"R Respiračný sys.",132,146.9,115.42500000000001,131.47142857142859,0.89857045609257991,1.1435997400909681]
[null,"* - krajiny s porovnateľným spôsobom vykazovania spotreby liekov "]

{"sheet":"graf_12","index":40,"n_rows":8,"n_cols":19,"rows_kept":8,"cut":false,"hidden":false,"merged":[]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Graf 12: Spotreba antibiotík (definované denné dávky na 1 000 obyv./deň)"]
[null,"Zdroj: OECD - Health - Pharmaceutical market - Pharmaceutical consumption"]
[null,"https://stats.oecd.org/"]
[null,null,2000,2001,2002,2003,2004,2005,2006,2007,2008,2009,2010,2011,2012,2013,2014,2015,2016]
[null,"SK",27.6,29.1,26.7,27.6,22.5,25.1,22.5,24.8,23.4,26.3,24.5,23.7,21.9,25.9,24.8,26.8,21.6]
[null,"V3",21.233333333333334,22.233333333333334,20.266666666666666,20.8,18.666666666666668,20.366666666666667,18.600000000000001,18.700000000000003,18.2,21.133333333333333,18.466666666666665,18.8,18.533333333333335,19.433333333333334,19.3,20.633333333333336,19]
[null,"EU28",20.778947368421058,20.905263157894737,19.854999999999997,20.555555555555557,19.085000000000001,20.155000000000005,19.919999999999998,20.861904761904761,20.847619047619052,20.75714285714286,19.954545454545457,20.347826086956523,19.926086956521733,20.373913043478261,19.973913043478262,20.591304347826085,19.900000000000002]
[null,"EU15",20.715384615384615,20.684615384615384,20.623076923076919,20.776923076923076,20.069230769230767,21.107692307692307,21.23076923076923,22.330769230769231,22.623076923076926,22.192307692307693,21.592857142857145,21.846666666666671,21.48,21.526666666666664,21.266666666666666,21.646666666666665,21.421428571428571]

{"sheet":"graf_13","index":41,"n_rows":8,"n_cols":19,"rows_kept":8,"cut":false,"hidden":false,"merged":[]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Graf 13: Spotreba generík (podiel generík na celkovej spotrebe liekov uhrádzaných z VZP, %)"]
[null,"Zdroj: OECD - Health - Pharmaceutical market - Pharmaceutical consumption"]
[null,"https://stats.oecd.org/"]
[null,null,2000,2001,2002,2003,2004,2005,2006,2007,2008,2009,2010,2011,2012,2013,2014,2015,2016]
[null,"SK",79.599999999999994,77.099999999999994,75.2,74.5,75.400000000000006,75,73.7,72.5,69.2,68.2,68,68.099999999999994,68.900000000000006,69.599999999999994,69.3,67.599999999999994,64.900000000000006]
[null,"EU28",34.442857142857136,35.485714285714288,33.075000000000003,31.580000000000005,31.018181818181823,34.009090909090915,35.754545454545458,37.375,34.914285714285711,36.428571428571431,38.592857142857149,40.342857142857142,41.693333333333342,44.126666666666658,46.721428571428575,47.9,49.083333333333343]
[null,"EU15",26.916666666666668,28.55,27.057142857142853,26.811111111111114,26.580000000000002,29.909999999999997,31.959999999999997,34.18181818181818,32.276923076923076,33.984615384615388,36.330769230769235,38.207692307692312,39.75,42.307142857142857,44.984615384615388,46.384615384615387,47.645454545454548]
[null,"OECD",30.455555555555559,31.511111111111113,30.160000000000004,29.658333333333335,29.569230769230767,32.530769230769231,34.5,36.035714285714285,36.835294117647052,38.27058823529412,40.352941176470594,42.000000000000007,43.19444444444445,45.466666666666661,47.811764705882354,48.958823529411767,50.220000000000013]

{"sheet":"graf_14","index":42,"n_rows":19,"n_cols":3,"rows_kept":19,"cut":false,"hidden":false,"merged":[]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Graf 14: Výdavky na generiká (podiel generík na celkových výdavkoch na lieky uhrádzaných z VZP, %)"]
[null,"Zdroj: OECD - Health - Pharmaceutical market - Generic market"]
[null,"https://stats.oecd.org/"]
[null,null,2016]
[null,"Rakúsko",48.4]
[null,"Belgicko",14.7]
[null,"Kanada",30.9]
[null,"Nemecko",34.1]
[null,"Írsko",15.6]
[null,"Taliansko",7.9]
[null,"Luxemburgsko",5.6]
[null,"Holandsko",16.8]
[null,"Nový Zéland",31]
[null,"Portugalsko",24.6]
[null,"Slovensko",27.2]
[null,"Španielsko",22.5]
[null,"Švajčiarsko",19.3]
[null,"Turecko",32.200000000000003]
[null,"Veľká Británia",37.6]

{"sheet":"graf_15","index":43,"n_rows":16,"n_cols":6,"rows_kept":16,"cut":false,"hidden":false,"merged":[[15,3,16,3],[15,4,16,4],[15,5,16,5]]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Graf 15: Rozptyl medzi 65 nemocnicami v kvalite zdravotnej starostlivosti"]
[null,"Zdroj: Štúdia k stratifikácii nemocníc MZ"]
[null,"Graf bol prevzatý bez podkladových dát"]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[null,null,null,null,null," "]

{"sheet":"graf_16","index":44,"n_rows":6,"n_cols":7,"rows_kept":6,"cut":false,"hidden":false,"merged":[]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Graf 16: Počet čakajúcich na plánované výkony k 31.12."]
[null,"Zdroj: výročné správy UDZS"]
[null,null,2013,2014,2015,2016,2017]
[null,"Choroby svalovej a kostrovej sústavy\na spojivového tkaniva vyžadujúce implantáciu zdravotníckej pomôcky",5300,4455,3343,2720,2648]
[null,"Choroby obehovej sústavy",920,433,243,388,455]
[null,"Choroby oka a jeho adnexov vyžadujúce implantáciu zdravotníckej pomôck",1587,686,255,23,88]

{"sheet":"graf_17","index":45,"n_rows":8,"n_cols":3,"rows_kept":8,"cut":false,"hidden":false,"merged":[]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Graf 17: Podiel populácie s časom dojazdu do 30 minút do najbližšej nemocnice"]
[null,"Zdroj: Štúdia k stratifikácii nemocníc MZ"]
[null,"Nemecko",0.99]
[null,"Slovensko ",0.91]
[null,"Rakúsko",0.9]
[null,"Dánsko",0.82]
[null,"Švédsko",0.78]
[null,"Francúzsko",0.75]

{"sheet":"graf_18","index":46,"n_rows":9,"n_cols":9,"rows_kept":9,"cut":false,"hidden":false,"merged":[]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Graf 18: Faktory ovplyvňujúce nárast záväzkov podľa účtovných závierok 13 najväčších nemocníc (2017)"]
[null,"Zdroj: účtovné závierky MF SR"]
[null,null,"Strata","Nárast záväzkov",".","HV + nárast aktív","Nárast pasív","Neprevádzkový HV","Nárast aktív"]
[null,"Strata",76.710094749999953,null,null,76.710094749999953]
[null,"Záväzky",null,121.11475312000003,null,null,121.11475312000003]
[null,"Neprevádzkové náklady",null,null,null,17.998579800000002,null,17.998579800000002]
[null,"Aktíva - Investície, pohľadávky, zásoby, časové rozlíšenie",null,null,null,39.062930790000017,null,null,39.062930790000017]
[null,"Pasíva - úvery, rezervy, časové rozlíšenie",null,null,null,null,10.242899550000001]
[null,"Pasíva - rezervný fond",null,null,null,null,2.4136454200000004]

{"sheet":"graf_19","index":47,"n_rows":5,"n_cols":7,"rows_kept":5,"cut":false,"hidden":false,"merged":[]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Graf 19: Vývoj straty a nárastu záväzkov 13 najväčších nemocníc MZ"]
[null,"Zdroj: Ministerstvo Zdravotníctva"]
[null,null,2013,2014,2015,2016,2017]
[null,"strata",20,51,64,81,77]
[null,"nárast záväzkov",112,68,109,101,118]

{"sheet":"graf_20","index":48,"n_rows":8,"n_cols":6,"rows_kept":8,"cut":false,"hidden":false,"merged":[]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Graf 20: Percento zaočkovaných proti chrípke, populácia 65+"]
[null,"Zdroj: OECD - Health - Health Care Utilization - Immunisation"]
[null,"http://stats.oecd.org/"]
[null,null,2013,2014,2015,2016]
[null,"SK",15.6,14.1,13.8,13.3]
[null,"V3",40.126315789473686,36.150000000000006,37.688888888888897,35.212500000000006]
[null,"EU-28",52.569230769230757,49.721428571428575,50.750000000000007,49.07]
[null,"EU-15",46.311111111111103,43.256250000000001,44.407407407407398,40.954166666666659]

{"sheet":"graf_21","index":49,"n_rows":8,"n_cols":7,"rows_kept":8,"cut":false,"hidden":false,"merged":[]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Graf 21: Percento žien (50-79), ktoré absolvovali skríning na rakovinu prsníka"]
[null,"Zdroj: OECD - Health - Health Care Utilization - Screening"]
[null,"http://stats.oecd.org/"]
[null,null,2013,2014,2015,2016,2017]
[null,"SK",31.6,30.5,30.1,30.4,30.8]
[null,"V3",50.6,51.45,51.9,51.7]
[null,"EU-28",58.675000000000004,60.682352941176468,58.481249999999996,58.878571428571419,58.375]
[null,"EU-15",66.5,68.539999999999992,65.51111111111112,69.05714285714285,59.5]

{"sheet":"graf_22","index":50,"n_rows":8,"n_cols":7,"rows_kept":8,"cut":false,"hidden":false,"merged":[]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Graf 22: Percento žien, ktoré absolvovali preventívnu prehliadku  u gynekológa (kŕčok maternice)"]
[null,"Zdroj: OECD - Health - Health Care Utilization - Screening"]
[null,"http://stats.oecd.org/"]
[null,null,2013,2014,2015,2016,2017]
[null,"SK",47.5,47.2,46.9,48.3,46]
[null,"V3",44.55,43.900000000000006,44.2,44.35]
[null,"EU-28",57.113333333333337,58.339999999999996,58.413333333333334,58.1,62.133333333333333]
[null,"EU-15",65.837499999999991,68.074999999999989,68.8,69.371428571428581,75.400000000000006]

{"sheet":"graf_23","index":51,"n_rows":5,"n_cols":5,"rows_kept":5,"cut":false,"hidden":false,"merged":[]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Graf 23: Podiel jednodňovej chirurgie na celkovom počte operácií"]
[null,"Zdroj: výkazy NCZI"]
[null,null,2015,2016,2017]
[null,"hospitalizácie",0.56605198771736809,0.56679919285557312,0.56285883671415371]
[null,"1-dňová chirurgia",0.43394801228263191,0.43320080714442688,0.43714116328584623]

{"sheet":"graf_24","index":52,"n_rows":5,"n_cols":6,"rows_kept":5,"cut":false,"hidden":false,"merged":[]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Graf 24: Podiel návštev v ambulanciách špecializovanej starostlivosti zo všetkých (%)"]
[null,"Zdroj: výkazy NCZI"]
[null,null,2013,2014,2015,2016]
[null,"VAS",0.49253682463130333,0.4979634327892688,0.49830157786339213,0.5041883955060904]
[null,"ŠAS",0.50746317536869667,0.5020365672107312,0.50169842213660787,0.4958116044939096]

{"sheet":"graf_25","index":53,"n_rows":8,"n_cols":18,"rows_kept":8,"cut":false,"hidden":false,"merged":[]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Graf 25: Počet CT strojov (na 1 mil. obyv.)"]
[null,"Zdroj: OECD - Health - Health Care Resources - Medical Technology"]
[null,"http://stats.oecd.org/"]
[null,null,2001,2002,2003,2004,2005,2006,2007,2008,2009,2010,2011,2012,2013,2014,2015,2016]
[null,"SK",null,null,9.1199999999999992,10.24,11.35,12.290000000000001,13.77,13.76,13.37,14.09,15.010000000000002,15.53,15.33,17.34,17.88,17.309999999999999]
[null,"V3",null,null,null,12.65,12.34,13.08,12.92,13.389999999999999,14.17,14.510000000000002,14.184999999999999,15.215,16.055,15.365,16.645,16.424999999999997]
[null,"EU28",15.595714285714287,16.32057142857143,15.831944444444444,15.604909090909089,17.480378151260503,17.830672268907563,18.677226890756302,19.557833333333335,19.541932773109242,21.252638888888885,21.601238390092877,22.447399380804953,23.421083591331268,23.781888544891643,23.896176470588234,23.877697368421053]
[null,"EU15",17.380833333333332,18.011666666666667,18.016666666666666,18.347333333333335,21.115681818181816,21.305681818181817,21.952727272727273,22.211555555555552,21.671250000000001,23.295333333333332,24.034333333333333,24.668833333333335,25.76433333333333,26.180499999999999,26.20569230769231,26.181666666666668]

{"sheet":"graf_26","index":54,"n_rows":8,"n_cols":19,"rows_kept":8,"cut":false,"hidden":false,"merged":[]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Graf 26: Počet CT vyšetrení (na 1 000 obyv.)"]
[null,"Zdroj: OECD - Health - Health Care Utilisation -  Computed Tomography exams"]
[null,"http://stats.oecd.org/"]
[null,null,2000,2001,2002,2003,2004,2005,2006,2007,2008,2009,2010,2011,2012,2013,2014,2015,2016]
[null,"SK",32,36.700000000000003,37.700000000000003,41.7,46.5,46.2,57.1,69.2,82.9,85.9,89.8,99.1,107.6,122.8,134.80000000000001,156.19999999999999,162.30000000000001]
[null,"V3",null,null,null,null,63.050000000000004,66.449999999999989,65.900000000000006,67.05,76,80.650000000000006,81.550000000000011,85.1,83.733333333333334,87.866666666666674,94.899999999999991,101.10000000000001,110.80000000000001]
[null,"EU28",62.466666666666669,67.466666666666654,86.924999999999997,83.28,86.166666666666671,83.300000000000011,86.3,93.070000000000007,116.74166666666667,103.69999999999999,99.853846153846163,105.13076923076922,115.57142857142857,116.02666666666666,119.46250000000001,125.0529411764706,129.17499999999998]
[null,"EU15",115.2,118.1,127.5,104.83333333333333,114.8,113.65,119.7,128.85999999999999,153.28571428571428,132.41666666666666,116.87500000000001,121.8125,141.15000000000003,134.63333333333333,134.61000000000001,135.73000000000002,137.91111111111113]

{"sheet":"graf_27","index":55,"n_rows":8,"n_cols":18,"rows_kept":8,"cut":false,"hidden":false,"merged":[]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Graf 27: Počet MR strojov (na 1 mil. obyv.)"]
[null,"Zdroj: OECD - Health - Health Care Resources - Medical Technology"]
[null,"http://stats.oecd.org/"]
[null,null,2001,2002,2003,2004,2005,2006,2007,2008,2009,2010,2011,2012,2013,2014,2015,2016]
[null,"SK",1.3,2.0499999999999998,2.0499999999999998,3.72,4.28,4.47,5.77,6.13,6.13,6.86,7.04,6.29,6.65,8.3000000000000007,8.85,9.02]
[null,"V3",1.9100000000000001,1.7866666666666664,2.0133333333333332,2.44,2.5766666666666667,2.7766666666666668,3.2833333333333337,3.58,4.0766666666666671,4.6700000000000008,4.9000000000000004,5.0866666666666669,5.7433333333333332,5.7166666666666659,6.5100000000000007,6.7866666666666662]
[null,"EU28",5.8172727272727265,6.3792307692307686,6.7935714285714282,7.4779999999999998,7.8131250000000012,8.2942105263157888,9.3549999999999969,10.15263157894737,11.503333333333336,11.733157894736843,12.477368421052633,12.835263157894737,13.256842105263157,13.871578947368421,15.190000000000001,15.186470588235295]
[null,"EU15",8.2871428571428574,9.3312499999999989,10.603750000000003,11.007777777777777,11.845555555555556,11.803636363636361,13.319999999999999,13.6,16.151,15.776363636363635,16.554545454545455,16.715454545454545,16.997272727272726,17.714545454545455,20.05,19.776666666666664]

{"sheet":"graf_28","index":56,"n_rows":8,"n_cols":19,"rows_kept":8,"cut":false,"hidden":false,"merged":[]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Graf 28: Počet MR vyšetrení (na 1 000 obyv.)"]
[null,"Zdroj: OECD - Health - Health Care Utilisation - Medical Technology"]
[null,"http://stats.oecd.org/"]
[null,null,2000,2001,2002,2003,2004,2005,2006,2007,2008,2009,2010,2011,2012,2013,2014,2015,2016]
[null,"SK",3.1,3.5,3.5,5.2,7.9,9.8000000000000007,13.3,20.8,24.3,29.9,33.5,34.700000000000003,40.9,46.3,51.6,56.8,61.4]
[null,"V3",null,null,null,null,16.5,18.8,25.299999999999997,26.2,29.1,31.799999999999997,32.65,35.85,33.5,34.666666666666664,36.300000000000004,38.033333333333331,40.699999999999996]
[null,"EU28",13.100000000000001,17.5,20.6,21.119999999999997,22.771428571428572,30.762500000000003,31.281818181818178,34.827272727272728,43.630769230769232,44.458333333333336,47.535714285714285,51.785714285714285,54.013333333333328,57.443749999999994,60.91764705882354,63.594444444444434,61.841176470588245]
[null,"EU15",23.1,31.5,29.150000000000002,31.966666666666669,40.333333333333336,50.075000000000003,50.679999999999993,55.06,62.757142857142853,64.566666666666677,63.2,66.6875,72.4375,74.1111111111111,76.37,79.809999999999974,74.48888888888888]

{"sheet":"graf_29","index":57,"n_rows":7,"n_cols":5,"rows_kept":7,"cut":false,"hidden":false,"merged":[]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Graf 29: Nárasty počtu vyšetrení na CT a MR v rokoch 2016 – 2018"]
[null,"Zdroj: Ministerstvo Zdravotníctva"]
[null,null,2016,2017,2018]
[null,"CT",993865,992912,1028576]
[null,"MR",348637,365736,398980]
[null,"CT % zmena",null,4.9045282000000003E-2,9.0896166E-2]
[null,"MR % zmena",null,-9.58883E-4,3.5918591E-2]

{"sheet":"graf_30","index":58,"n_rows":8,"n_cols":18,"rows_kept":8,"cut":false,"hidden":false,"merged":[]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Graf 30: Počet PET strojov (na 1 mil. obyv.)"]
[null,"Zdroj: OECD - Health - Health Care Utilisation - Medical Technology"]
[null,"http://stats.oecd.org/"]
[null,null,2001,2002,2003,2004,2005,2006,2007,2008,2009,2010,2011,2012,2013,2014,2015,2016]
[null,"SK",0.19,0.19,0.19,0.19,0.56000000000000005,0.56000000000000005,0.56000000000000005,0.56000000000000005,0.56000000000000005,0.56000000000000005,0.93,0.92,1.1100000000000001,1.29,1.47,1.47]
[null,"V3",0.1,0.1,0.19500000000000001,0.29499999999999998,0.495,0.54499999999999993,0.54499999999999993,0.55999999999999994,0.46333333333333332,0.49666666666666665,0.52666666666666673,0.53666666666666674,0.59,0.66,0.74333333333333329,0.93333333333333346]
[null,"EU28",0.25111111111111112,0.25888888888888889,0.56777777777777783,0.71083333333333343,0.8726666666666667,0.96923076923076923,1.1539999999999999,1.2447058823529409,1.3594117647058825,1.0900000000000001,1.4683333333333333,1.3541176470588236,1.6644444444444444,1.7455555555555555,1.8683333333333334,1.9499999999999995]
[null,"EU15",0.46750000000000008,0.48499999999999999,1.1325000000000001,1.2083333333333333,1.3800000000000001,1.6183333333333334,1.7087500000000002,1.8255555555555556,2.0755555555555554,1.5555555555555556,2.069,1.8800000000000001,2.3490000000000002,2.4220000000000002,2.5990000000000002,2.7166666666666668]

{"sheet":"graf_31","index":59,"n_rows":8,"n_cols":18,"rows_kept":8,"cut":false,"hidden":false,"merged":[]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Graf 31:  Počet PET vyšetrení (na 1 000 obyv.) "]
[null,"Zdroj: OECD - Health - Health Care Utilisation - Medical Technology"]
[null,"http://stats.oecd.org/"]
[null,null,2001,2002,2003,2004,2005,2006,2007,2008,2009,2010,2011,2012,2013,2014,2015,2016]
[null,"SK",null,null,null,null,null,null,null,null,0.7,0.7,0.7,1,1.2,1.5,1.6,1.9]
[null,"V3",null,null,null,null,0.1,0.95,1.2,1.3,1.45,1.8,2.2000000000000002,1.7999999999999998,1.8666666666666665,1.9333333333333336,2.1333333333333333,2.4333333333333336]
[null,"EU28",2.5,1.75,1.5999999999999999,1.7,1.9749999999999999,1.8666666666666665,2.1166666666666667,2.2285714285714286,2.1555555555555554,2.1636363636363636,2.418181818181818,2.3583333333333334,2.569230769230769,2.8857142857142857,2.7857142857142856,2.8733333333333335]
[null,"EU15",2.5,1.75,1.5999999999999999,2.2333333333333334,2.6,3.0999999999999996,3.4333333333333336,3.25,3.16,2.7857142857142856,3.0714285714285716,3.128571428571429,3.3,3.6555555555555554,3.7250000000000005,4.0875000000000004]

{"sheet":"graf_32","index":60,"n_rows":8,"n_cols":18,"rows_kept":8,"cut":false,"hidden":false,"merged":[]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Graf 32: Úmrtnosť na infarkt myokardu do 30 dní od hospitalizácie (na 100 000 obyv., vo veku 45+)"]
[null,"Zdroj: OECD - Health - Health Care Quality Indicators - Acute Care"]
[null,"http://stats.oecd.org/"]
[null,null,2000,2001,2002,2003,2004,2005,2006,2007,2008,2009,2010,2011,2012,2013,2014,2015]
[null,"SK",null,null,null,null,null,null,null,11.8,null,9,8.1,7.6,7.2,6.9,6.2,6.4]
[null,"V3",null,null,null,null,13.200000000000001,12.95,11.7,10.366666666666667,10.1,9.0666666666666664,5.7,6,4.9000000000000004,5.7,4.5,5.65]
[null,"EU28",13.9125,11.712500000000002,11.25,10.711111111111112,10.775,10.115384615384615,9.3692307692307697,9.2625000000000011,8.8625000000000007,8.1999999999999993,7.2562499999999996,6.9722222222222223,7.0117647058823538,7.57,6.9625000000000004,7.2000000000000011]
[null,"EU15",13.657142857142857,11.712500000000002,11.25,10.711111111111112,9.9666666666666668,9.6,8.9454545454545453,8.7750000000000004,8.2461538461538471,7.5769230769230758,7.3461538461538458,7.05,6.5916666666666659,6.9230769230769234,6.25,6.28]

{"sheet":"graf_33","index":61,"n_rows":7,"n_cols":6,"rows_kept":7,"cut":false,"hidden":false,"merged":[]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Graf 33: Počet čakateľov na poskytovanie starostlivosti v zariadeniach sociálnych služieb"]
[null,"Zdroj: MPSVaR"]
[null,null,2014,2015,2016,2017]
[null,"zariadenia pre seniorov",1717,3427,4541,5525]
[null,"špecializované zariadenia",266,690,1316,1986]
[null,"ostatné ZSS",2538,1883,1842,2075]
[null,"*špecializované zariadenia – zariadenie pre pacientov so špecifickými diagnózami, napr. Alzheimerovou chorobou."]

{"sheet":"graf_34","index":62,"n_rows":10,"n_cols":3,"rows_kept":10,"cut":false,"hidden":false,"merged":[]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Graf 34: Počet hospitalizácií, resp. pacientov podľa typu dlhodobej starostlivosti, 2017"]
[null,"Zdroj: Ministerstvo Zdravotníctva"]
[null,null,2016]
[null,"Nemocnice (DS)",36171]
[null,"Domy ošetrovateľskej starostlivosti",2714]
[null,"Hospice",1132]
[null,"Zariadenia sociálnych služieb",30000]
[null,"ADOS (DS)",8000]
[null,"DS – iba dlhodobá starostlivosť"]
[null,"Zariadenia sociálnych služieb - dĺžka pobytu 365 dní v roku."]

{"sheet":"graf_35","index":63,"n_rows":10,"n_cols":4,"rows_kept":10,"cut":false,"hidden":false,"merged":[]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Graf 35: Dĺžka pobytu a náklady na dlhodobú starostlivosť podľa typu služby, 2016"]
[null,"Zdroj: Ministerstvo Zdravotníctva"]
[null,"Rok 2016","osobo-mesiace","priemerné mesačné náklady na osobu (pravá os)"]
[null,"Nemocnice (DS)",22856.233333333334,1650.3792881917932]
[null,"Hospice",1611,988.56797020484169]
[null,"Domy ošetrovateľskej starostlivosti",809.1,858.09047089358546]
[null,"Zariadenia sociálnych služieb",365000,685]
[null,"ADOS (DS)",null,115]
[null,"ADOS – agentúra domácej ošetrovateľskej služby. Pre ADOS nie sú dostupné údaje k osobo-mesiacom."]
[null,"Zariadenia sociálnych služieb - dĺlžka pobytu 365 dní v roku. Uvedené náklady iba od MPSVaR, zdroje od VÚC a súkromnými poplatkami spolu priemerne 1 100 €."]

{"sheet":"graf_36","index":64,"n_rows":5,"n_cols":6,"rows_kept":5,"cut":false,"hidden":false,"merged":[]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Graf 36: Počet hospitalizácií s diagnózou, ktorá má byť manažovaná domácou starostlivosťou, populácia 65+"]
[null,"NCZI - registre HOSP (Z01)"]
[null,null,2013,2014,2015,2016]
[null,"dehydratácia",null,3224,3900,3863]
[null,"dekubity",null,342,339,303]

{"sheet":"graf_37","index":65,"n_rows":15,"n_cols":7,"rows_kept":15,"cut":false,"hidden":false,"merged":[]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Graf 37: Dojčenská úmrtnosť (počet smrtí v prvom roku života na 1 000 živonarodených)"]
[null,"Zdroj:  Register fyzických osôb, Atlas rómskych komunít 2013, Eurostat, výpočty ÚHP"]
[null,"Rok narodenia","MRK","Zvysok populacie","Cela populacia","EU28","V3"]
[null,2006,13.281599761229668,5.6352350486197906,6.5857821311962006,4.5999999999999996,5]
[null,2007,14.18545617440645,5.0076476627485489,6.1369983830662944,4.4000000000000004,5]
[null,2008,12.483669618231962,4.9533395415188926,5.8577405857740592,4.2,4.6666666666666661]
[null,2009,11,4.9615434273382881,5.6520247643628405,4.2,4.5333333333333332]
[null,2010,10.459634649381261,5.0911939129461787,5.6944214534017545,4,4.333333333333333]
[null,2011,11.499402628434886,4.1207014431694295,4.9331557397267032,3.9,4.1000000000000005]
[null,2012,12.721893491124261,4.8180420297283444,5.780138651300982,3.8,4.0333333333333332]
[null,2013,11.389872248730184,4.6972644125315561,5.4903963664885174,3.7,4.0333333333333332]
[null,2014,13.010053222945004,4.7649630197435204,5.7783511711155127,3.7,3.7000000000000006]
[null,2015,15.386936189470509,3.7367529046617527,5.1257149023416426,3.6,3.5666666666666664]
[null,2016,13.85165326184093,4.2877092225085063,5.403339298434596,3.6,3.5666666666666664]
[null,"Pozn.: Všetky hodnoty priraďujú ľudí do jednotlivých krajín podľa ich  trvalého pobytu."]

{"sheet":"graf_38","index":66,"n_rows":9,"n_cols":12,"rows_kept":9,"cut":false,"hidden":false,"merged":[]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Graf 38: Očakávaná dĺžka života pri narodení (v rokoch)"]
[null,"Zdroj:  Register fyzických osôb, Atlas rómskych komunít 2013, Eurostat, výpočty ÚHP"]
[null,"Populacia",2006,2007,2008,2009,2010,2011,2012,2013,2014,2015]
[null,"MRK, skratene",69.446221861373402,69.627860833799005,70.047347307572494,70.8636077801212,70.293264580907504,71.123586250853705,70.824170384801903,69.7573344384042,70.2390024409208,69.694018318135406]
[null,"Zvysok populacie",74.638721004420901,74.649186560785296,75.026817284714497,75.350308065547097,75.5096268662939,76.005499247111501,76.154989834600599,76.459878134342105,76.847051801396105,76.373248375921307]
[null,"Cela populacia",74.274592424457296,74.291036734760993,74.692279984789707,75.007165908276505,75.175703432668996,75.678200342501299,75.7520570432238,76.0445053439622,76.419409469279501,75.970384587886002]
[null,"EU28",78.900000000000006,79.099999999999994,79.400000000000006,79.599999999999994,79.900000000000006,80.2,80.3,80.5,80.900000000000006,80.599999999999994]
[null,"V3",75.166666666666671,75.333333333333329,75.7,75.900000000000006,76.266666666666666,76.633333333333326,76.766666666666666,77.066666666666663,77.566666666666663,77.3]
[null,"Pozn.: Slovenské hodnoty (pre celú populáciu, MRK aj  zvyšok populácie) sú očistené o ľudí s prechodným pobytom v zahraničí. Priemer V3 aj EÚ-28 používa trvalý pobyt."]

{"sheet":"graf_39","index":67,"n_rows":27,"n_cols":4,"rows_kept":27,"cut":false,"hidden":false,"merged":[]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Graf 39: Vzťah bohatstva krajiny a výdavkov na zdravotníctvo, 2017"]
[null,"Zdroj: OECD - Health - Health expenditure and financing; OECD - National Accounts - Gross Domesting Product (Per head, constant prices, constant PPPs, OECD base year)"]
[null,"http://stats.oecd.org/"]
[null,"Country","HDP na obyvateľa","Podiel na HDP (%)"]
[null,"France",{"$f":"VLOOKUP(B5,'[2]GDP per head, US $, constant pr'!$A$7:$E$46,5,FALSE)","v":36823.024695},{"$f":"VLOOKUP(B5,'[2]Share of GDP'!$A$9:$D$44,4,FALSE)","v":8.8079999999999998}]
[null,"Spain",{"$f":"VLOOKUP(B6,'[2]GDP per head, US $, constant pr'!$A$7:$E$46,5,FALSE)","v":31765.678969000001},{"$f":"VLOOKUP(B6,'[2]Share of GDP'!$A$9:$D$44,4,FALSE)","v":6.5010000000000003}]
[null,"Netherlands",{"$f":"VLOOKUP(B7,'[2]GDP per head, US $, constant pr'!$A$7:$E$46,5,FALSE)","v":46068.792672000003},{"$f":"VLOOKUP(B7,'[2]Share of GDP'!$A$9:$D$44,4,FALSE)","v":8.423}]
[null,"Luxembourg",{"$f":"VLOOKUP(B8,'[2]GDP per head, US $, constant pr'!$A$7:$E$46,5,FALSE)","v":87919.227971},{"$f":"VLOOKUP(B8,'[2]Share of GDP'!$A$9:$D$44,4,FALSE)","v":5.0979999999999999}]
[null,"Italy",{"$f":"VLOOKUP(B9,'[2]GDP per head, US $, constant pr'!$A$7:$E$46,5,FALSE)","v":33203.846474999998},{"$f":"VLOOKUP(B9,'[2]Share of GDP'!$A$9:$D$44,4,FALSE)","v":6.702}]
[null,"Belgium",{"$f":"VLOOKUP(B10,'[2]GDP per head, US $, constant pr'!$A$7:$E$46,5,FALSE)","v":40829.307907000002},{"$f":"VLOOKUP(B10,'[2]Share of GDP'!$A$9:$D$44,4,FALSE)","v":7.923}]
[null,"Sweden",{"$f":"VLOOKUP(B11,'[2]GDP per head, US $, constant pr'!$A$7:$E$46,5,FALSE)","v":44280.846699000002},{"$f":"VLOOKUP(B11,'[2]Share of GDP'!$A$9:$D$44,4,FALSE)","v":9.1739999999999995}]
[null,"Denmark",{"$f":"VLOOKUP(B12,'[2]GDP per head, US $, constant pr'!$A$7:$E$46,5,FALSE)","v":44481.651667999999},{"$f":"VLOOKUP(B12,'[2]Share of GDP'!$A$9:$D$44,4,FALSE)","v":8.6489999999999991}]
[null,"Austria",{"$f":"VLOOKUP(B13,'[2]GDP per head, US $, constant pr'!$A$7:$E$46,5,FALSE)","v":43052.617229000003},{"$f":"VLOOKUP(B13,'[2]Share of GDP'!$A$9:$D$44,4,FALSE)","v":7.6660000000000004}]
[null,"Ireland",{"$f":"VLOOKUP(B14,'[2]GDP per head, US $, constant pr'!$A$7:$E$46,5,FALSE)","v":59886.191103999998},{"$f":"VLOOKUP(B14,'[2]Share of GDP'!$A$9:$D$44,4,FALSE)","v":5.3010000000000002}]
[null,"Portugal",{"$f":"VLOOKUP(B15,'[2]GDP per head, US $, constant pr'!$A$7:$E$46,5,FALSE)","v":26701.888977999999},{"$f":"VLOOKUP(B15,'[2]Share of GDP'!$A$9:$D$44,4,FALSE)","v":5.9359999999999999}]
[null,"Finland",{"$f":"VLOOKUP(B16,'[2]GDP per head, US $, constant pr'!$A$7:$E$46,5,FALSE)","v":37886.510014},{"$f":"VLOOKUP(B16,'[2]Share of GDP'!$A$9:$D$44,4,FALSE)","v":7.2990000000000004}]
[null,"Germany",{"$f":"VLOOKUP(B17,'[2]GDP per head, US $, constant pr'!$A$7:$E$46,5,FALSE)","v":42732.313966000002},{"$f":"VLOOKUP(B17,'[2]Share of GDP'!$A$9:$D$44,4,FALSE)","v":9.3390000000000004}]
[null,"United Kingdom",{"$f":"VLOOKUP(B18,'[2]GDP per head, US $, constant pr'!$A$7:$E$46,5,FALSE)","v":38528.306822999999},{"$f":"VLOOKUP(B18,'[2]Share of GDP'!$A$9:$D$44,4,FALSE)","v":7.7930000000000001}]
[null,"Greece",{"$f":"VLOOKUP(B19,'[2]GDP per head, US $, constant pr'!$A$7:$E$46,5,FALSE)","v":23707.159023},{"$f":"VLOOKUP(B19,'[2]Share of GDP'!$A$9:$D$44,4,FALSE)","v":4.7759999999999998}]
[null,"Slovenia",{"$f":"VLOOKUP(B20,'[2]GDP per head, US $, constant pr'!$A$7:$E$46,5,FALSE)","v":28117.492645999999},{"$f":"VLOOKUP(B20,'[2]Share of GDP'!$A$9:$D$44,4,FALSE)","v":6.0819999999999999}]
[null,"Poland",{"$f":"VLOOKUP(B21,'[2]GDP per head, US $, constant pr'!$A$7:$E$46,5,FALSE)","v":24186.070030999999},{"$f":"VLOOKUP(B21,'[2]Share of GDP'!$A$9:$D$44,4,FALSE)","v":4.4400000000000004}]
[null,"Czech Republic",{"$f":"VLOOKUP(B22,'[2]GDP per head, US $, constant pr'!$A$7:$E$46,5,FALSE)","v":29903.394382999999},{"$f":"VLOOKUP(B22,'[2]Share of GDP'!$A$9:$D$44,4,FALSE)","v":5.9660000000000002}]
[null,"Estonia",{"$f":"VLOOKUP(B23,'[2]GDP per head, US $, constant pr'!$A$7:$E$46,5,FALSE)","v":26270.381378999999},{"$f":"VLOOKUP(B23,'[2]Share of GDP'!$A$9:$D$44,4,FALSE)","v":4.9009999999999998}]
[null,"Slovakia",{"$f":"VLOOKUP(B24,'[2]GDP per head, US $, constant pr'!$A$7:$E$46,5,FALSE)","v":28122.395453000001},{"$f":"VLOOKUP(B24,'[2]Share of GDP'!$A$9:$D$44,4,FALSE)","v":5.4749999999999996}]
[null,"Hungary",{"$f":"VLOOKUP(B25,'[2]GDP per head, US $, constant pr'!$A$7:$E$46,5,FALSE)","v":24086.472591000002},{"$f":"VLOOKUP(B25,'[2]Share of GDP'!$A$9:$D$44,4,FALSE)","v":4.7610000000000001}]
[null,"Latvia",{"$f":"VLOOKUP(B26,'[2]GDP per head, US $, constant pr'!$A$7:$E$46,5,FALSE)","v":22168.513939},{"$f":"VLOOKUP(B26,'[2]Share of GDP'!$A$9:$D$44,4,FALSE)","v":3.2570000000000001}]
[null,"Lithuania",{"$f":"VLOOKUP(B27,'[2]GDP per head, US $, constant pr'!$A$7:$E$46,5,FALSE)","v":25813.242237999999},{"$f":"VLOOKUP(B27,'[2]Share of GDP'!$A$9:$D$44,4,FALSE)","v":4.3479999999999999}]

{"sheet":"graf_40","index":68,"n_rows":8,"n_cols":14,"rows_kept":8,"cut":false,"hidden":false,"merged":[]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Graf 40: Výdavky na zdravotníctvo ako % verejných výdavkov"]
[null,"Zdroj: Eurostat: General government expenditure by function (COFOG) [gov_10a_exp]; "]
[null,"http://ec.europa.eu/eurostat/web/lfs/data/database"]
[null,null,2010,2011,2012,2013,2014,2015,2016,2017,2018,2019,2020,2021]
[null,"SK",0.17107905787840055,0.16701933550253575,0.16689517425819667,0.16523297957483912,0.1671455594290806,0.15788456204348886,0.17736855074055713,0.18429640895256785,0.18115162173116336,0.18570260551828324,0.17386724158477859,0.17379868045498661]
[null,"V3",0.1298142080050583,0.12947906107578769,0.12903667330035187,0.1300353334983331,0.12896943416569218,0.13277112522772963,0.13493250163001971]
[null,"EU15",0.14498967549505631,0.14628569959525595,0.14522756190824673,0.14614025223715355,0.14828666947667782,0.14877250765396546,0.14969634129678733]
[null,"EU28",0.14562631768922521,0.14664731687482391,0.14599843514958,0.14761415675013678,0.15037587310808398,0.15201576155897026,0.15320614541592192]

{"sheet":"graf_41","index":69,"n_rows":27,"n_cols":4,"rows_kept":27,"cut":false,"hidden":false,"merged":[]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Graf 41: Vzťah medzi zdravotným stavom obyvateľstva a výdavkami na zdravotníctvo, 2017"]
[null,"Zdroj: Eurostat: Amenable and preventable deaths of residents (hlth_cd_apr); OECD - Health - Health expenditure and financing; "]
[null,"http://ec.europa.eu/eurostat/web/lfs/data/database; ",null,"http://stats.oecd.org"]
[null,null,"Verejné výdavky na zdravotníctvo","Odvratiteľná úmrtnosť na 100 tisíc obyvateľov"]
[null,"Francúzsko",3248.55,77.790000000000006]
[null,"Španielsko",2063.58,87.55]
[null,"Holandsko",3831.922,90.55]
[null,"Luxembursko",4925.09,90.94]
[null,"Taliansko",2225.489,92.98]
[null,"Belgicko",3224.3710000000001,94.04]
[null,"Švédsko",4062.2759999999998,96.73]
[null,"Dánsko",3846.14,97.84]
[null,"Rakúsko",3295.5590000000002,109.16]
[null,"Írsko",3170.5070000000001,110.52]
[null,"Portugalsko",1585.1130000000001,111.04]
[null,"Fínsko",2765.8580000000002,111.3]
[null,"Nemecko",3981.442,116.13]
[null,"Spojené kráľovstvo",2985.7240000000002,117.44]
[null,"Grécko",1132.19,126.99]
[null,"Slovinsko",1709.9739999999999,128.06]
[null,"Poľsko",1087.021,168.53]
[null,"Česká republika",1783.4870000000001,179.48]
[null,"Estónsko",1282.72,224.06]
[null,"Slovensko",1539.1559999999999,249.96]
[null,"Maďarsko",1146.749,267.67]
[null,"Lotyšsko",721.97900000000004,325.63]
[null,"Litva",1122.415,325.89999999999998]

{"sheet":"graf_42","index":70,"n_rows":8,"n_cols":4,"rows_kept":8,"cut":false,"hidden":false,"merged":[]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Graf 42: Výdavky na zdravotníctvo (% HDP)"]
[null,"Zdroj: Ageing working group, Európska komisia (2018)"]
[null,"https://ec.europa.eu/info/sites/info/files/economy-finance/ip079_en.pdf"]
[null,null,"úroveň 2017","nárast do 2070"]
[null,"SK",5.6849999999999996,1.1019487049164276]
[null,"V3",5.0843333333333334,0.708235878350853]
[null,"EU28",6.5390952380952383,0.20133843964930317]
[null,"EU15",7.5119999999999996,-0.17244004037689833]

{"sheet":"graf_43","index":71,"n_rows":8,"n_cols":10,"rows_kept":8,"cut":false,"hidden":false,"merged":[]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Graf 43: Prognóza vývoja vekovej štruktúry slovenského obyvateľstva"]
[null,"Zdroj: Eurostat: Population on 1st January by age, sex and type of projection [proj_15npms]"]
[null,"http://ec.europa.eu/eurostat/web/lfs/data/database"]
[null,null,2015,2020,2030,2040,2050,2060,"2070",2080]
[null,"0-14",0.15313181276468274,0.15461652351339636,0.14373085606874861,0.13489022887030683,0.13956187166321177,0.14151082104653959,0.14135474204532375,0.14630406149186492]
[null,"15-64",0.69505873907029414,0.66608002098661256,0.63372380837520736,0.60684010904063113,0.55488368672016486,0.52712974893295039,0.53582316219197557,0.53359506402221102]
[null,"65-79",0.12073618577221279,0.14570948709935189,0.17384615750634266,0.18126078648542363,0.21654896819585034,0.21280948349519119,0.18020658374932902,0.18012755659342874]
[null,"80+",3.1073262392810351E-2,3.3593968400639128E-2,4.8699178049701336E-2,7.700887560363838E-2,8.9005473420773001E-2,0.11854994652531885,0.14261551201337161,0.13997331789249529]

{"sheet":"graf_44","index":72,"n_rows":8,"n_cols":3,"rows_kept":8,"cut":false,"hidden":false,"merged":[]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Graf 44: Plat lekára ako násobok priemernej mzdy, 2015"]
[null,"Zdroj: OECD - Health - Health Care resources - Remuneration of Doctors"]
[null,"Health at Glance 2017, Kapitola 8"]
[null,"http://stats.oecd.org/"]
[null,"SK",2.33]
[null,"V3",2.0766666666666667]
[null,"EU-28",2.5931578947368421]
[null,"EU-15",2.8991666666666664]

{"sheet":"graf_45","index":73,"n_rows":8,"n_cols":3,"rows_kept":8,"cut":false,"hidden":false,"merged":[]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Graf 45: Plat sestry ako násobok priemernej mzdy, 2015"]
[null,"Zdroj: OECD - Health - Health Care resources - Remuneration of hospital nurses"]
[null,"Health at Glance 2017, Kapitola 8"]
[null,"SK pred zvýšením",0.97]
[null,"SK po zvýšení",1.0669999999999999]
[null,"V3",1.0999999999999999]
[null,"EU-28",1.1044482758620688]
[null,"EU-15",1.1260742705570292]

{"sheet":"graf_46","index":74,"n_rows":3,"n_cols":2,"rows_kept":3,"cut":false,"hidden":false,"merged":[]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Graf 46: Vzťah kvality a objemu zdravotnej starostlivosti"]
[null,"Zdroj: Štúdia k stratifikácii nemocníc MZ"]
[null,"Graf bol prevzatý bez podkladových dát"]

{"sheet":"graf_47","index":75,"n_rows":34,"n_cols":2,"rows_kept":34,"cut":false,"hidden":false,"merged":[]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Graf 47:  Rozsah a medián objemu resekcie rakoviny pažeráka podľa poskytovateľa, 2014-2016"]
[null,"Zdroj: Ministerstvo Zdravotníctva"]
[null,"Graf bol prevzatý bez podkladových dát"]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[null,"Pozn.: Leapfrod Threshold – limit podľa organizácie Leapfrog, Country Threshold – limit daný v krajine (na Slovensku)"]

{"sheet":"graf_48","index":76,"n_rows":50,"n_cols":6,"rows_kept":50,"cut":false,"hidden":false,"merged":[]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Graf 48: Výdavky poisťovní na lieky na výnimky v 1. polroku 2016, 2017 a 2018 "]
[null,"Zdroj: Implementačná jednotka, dáta zdravotných poisťovni"]
[null,null,null,"Dôvera","Union","VšZP"]
[null,"Január ",16,493450.86,114464.16,1974832.9000000001]
[null,null,17,877834.96499799995,107102.89,2311220.9500000002]
[null,null,18,604634.72,109076.78,2143339.5499999998]
[null," "]
[null,"Február",16,474538.022,120194.69,2232865.3199999998]
[null,null,17,826998.32849999995,100835.77,2261231.61]
[null,null,18,525294.38500000001,103393.95,2125969.54]
[null," "]
[null,"Marec",16,852798.57099799998,108682.41,2518141.61]
[null,null,17,731721.34499999997,115797.12,2139987.5099999998]
[null,null,18,551753.995,112637.93,2279325.7200000002]
[null," "]
[null,"Apríl",16,812371.06099999999,144742.54999999999,2385774.2799999998]
[null,null,17,706383.21199900005,127639.6,2072608.4]
[null,null,18,634713.37,139376.31,2472307.5499999998]
[null," "]
[null,"Máj",16,812995.19050000003,116021.66,2393524.81]
[null,null,17,731142.33999600005,136128.29,2432197.69]
[null,null,18,753265.21,118998.14,2610064.41]
[null," "]
[null,"Jún",16,997032.16899999999,141049.38,2463390.48]
[null,null,17,790090.09,117469.18,2422026.54]
[null,null,18,660549.63,84945.09,2786940.53]
[null," "]
[null,"Júl",16,928973.67499800003,90020.57,2275656.9]
[null,null,17,728822.67,110075.68,2300204.86]
[null,null,18,0,0,0]
[null," "]
[null,"August",16,908726.55499800004,86461.37,2625410.2200000002]
[null,null,17,833003.7,103739.78,2570619.86]
[null,null,18,0,0,0]
[null," "]
[null,"September",16,909188.03500000003,121251.96,2524394.87]
[null,null,17,769137.58,79013.87,2464994.75]
[null,null,18,0,0,0]
[null," "]
[null,"Október",16,1097003.085,109944.71,3002738.25]
[null,null,17,1006444.619998,112073.22,2957077.49]
[null,null,18,0,0,0]
[null," "]
[null,"November",16,963500.51899500005,143095.9,2702453.27]
[null,null,17,775099.86,99424.35,2596161.04]
[null,null,18,0,0,0]
[null," "]
[null,"December",16,806561.03799999994,90958.57,2645186.4]
[null,null,17,528661.47,90371.12,2269280.14]
[null,null,18,0,0,0]

{"sheet":"graf_49","index":77,"n_rows":7,"n_cols":5,"rows_kept":7,"cut":false,"hidden":false,"merged":[]}
[{"$f":"HYPERLINK(\"#Zoznam!A1\", \"Na zoznam\")","v":"Na zoznam"},"Graf 49: Výdavky poisťovní na lieky na výnimky v prepočte na 1 000 poistencov"]
[null,"Zdroj: Implementačná jednotka, dáta zdravotných poisťovni"]
[null,null,"1H2016","1H2017","1H2018"]
[null,"Dôvera",3136.6868100163642,3288.0052677314225,2522.366176782833]
[null,"Union",1701.9778811695296,1460.9837047414376,1399.506717725709]
[null,"VšZP",4268.5794890427751,4199.0611026755969,4515.6827372065363]
[null,"Pozn.: 1H označuje 1. polrok."]